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Chapter 1 
Introduction
The aim of this investigation was to study the 
effects that opiate administration, during the perinatal 
period, might have on various aspects of sexual 
differentiation of the central nervous system in the 
rodent. The processes of particular interest were,
1. Differentiation of masculine and feminine sexual 
behaviour in the adult golden hamster.
2. The levels of hypothalamic biogenic amines in the 
brain of the golden hamster on days 4 and 12 after birth.
3. The volume of the sexually dimorphic nucleus of the 
preoptic area (SDN-POA) in the adult rat.
4. The number of motoneurones in the spinal nucleus of the 
bulbocavernosus (SNB) in the adult rat.
5. Plasma testosterone levels in 2 day old male hamsters. 
To give a better understanding of the work carried out for 
this thesis I will give a brief outline of the various 
processes of sexual differentiation taking place in the 
mammal from the time of conception leading up to the 
perinatal period.
Mammalian Sexual differentiation
Sexual differentiation occurs as a sequential array of 
events. The process of mammalian sexual differentiation 
begins with the establishment of the chromosome complement 
of the individual at fertilization with the pairing of the
3
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gametes. The genetic information carried in the egg and 
sperm will, under normal circumstances, determine the 
phenotypic sex, that is , XX results in a female phenotype 
and XY results in a male phenotype.
Thus under the direction of the genotypic sex, the 
indifferent gonads develop as either testes or ovaries. 
In males, once the testes have differentiated, the 
interstitial Leydig cells begin to secrete testosterone, 
which then acts to direct development of the internal sex 
ducts, the external genitalia, somatic tissue and finally 
the nervous system along male lines. If the gonads become 
ovaries, all subsequent differentiation will be along 
female lines, (see Fig. 1:1)
Chromosomal Sex
In most mammals, the chromosomes consist of xn pairs of 
autosomes plus 2X chromosomes in females and IX + 1Y in 
males. Thus, the possession of a Y chromosome results in 
maleness, and is responsible for triggering gonadal 
differentiation to form testes. The development of 
karyotyping techniques (Moorhead et al. 1960; Guthrie,
1962) revealed that some individuals with supernumerary X 
chromosomes ie, XXY or XXXY have a male phenotype although 
they may be sterile (Davis, 1981) . When the X and Y 
chromosomes pair to form the XY body during 
spermatogenesis, the X chromosome is inactivated, thus the 
supernumerary X may be coding for some factor which
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inhibits spermatogenesis (McLaren & Monk, 1981). While it 
is not uncommon for XO females (Turner's Syndrome) to be 
born and reach adulthood, no male individual has been 
recorded as YO, which implies that a minimum of 1 X is 
required for survival.
Females inherit 1 X chromosome from the mother and the 
other from the father, while males always inherit a 
maternal X and a paternal Y. During normal development, 
one of the X chromosomes in every somatic cell is randomly 
inactivated (heteropycnosis); thus all daughter cells in a 
clone will have the same X chromosome inactivated (Lyon, 
1962). This inactive X can be visualised as a Barr body in 
cells taken from a female (Barr & Bertram, 1949). The 
female body is therefore a mosaic of cells, some have the 
maternal X inactive while others have the paternal X 
inactive. Where there are more than two X's there will be 
a Barr body for each supernumerary X chromosome. 
Heteropycnosis does not occur in the germ cells and, during 
oogenesis, both X chromosomes are active.
It has become apparent that the genes which determine 
testicular differentiation are situated on the short arm of 
the Y chromosome, since loss of the long arm has no effect 
on testicular development; neither does translocation of 
the long arm onto an autosome (see review, Davis, 1981) . 
Duplication of the long arm and thus loss of the short arm 
results in ovarian development (Gordon & Ruddle, 1981).
Where on the short arm of the Y chromosome are these 
genes located? Eichwald and Silmser, (1955) described
transplantation experiments which they had carried out on 
highly inbred strains of mice. Here skin grafts from male 
mice were rejected by females of the same strain, yet, the 
reciprocal grafts were not. They deduced that this was 
caused by a chromosome histocompatability gene, which was 
subsequently named the H-Y antigen. Using serological 
assays to measure the male antigen, Wachtel et al (1975) 
found that where the male antigen was detected, testes were 
usually present. Thus they proposed that the H-Y antigen 
was the testis- determining gene.
Cattanach et al. (1971) described an autosomally-
inherited condition in mice which causes genetic females to 
develop as phenotypic males (Sxr) which have small testes 
and are sterile as adults. They found no evidence that the 
Sxr gene could have come from the Y chromosome and proposed 
that it was an autosomal gene mutation. However, in 1982, 
Singh and Jones reported that DNA hybridization techniques 
indicate that the Sxr gene consists of DNA which is related 
to that found on the Y chromosome. They suggested that the 
Sxr gene is transferred to the distal end of the X 
chromosome from the distal end of the Y chromosome in the 
carrier male XYSxr during meiosis. These findings were 
confirmed by Evans et al (1982) who reported that XYSxr 
males have an abnormal Y chromosome possessing an extra 
dark-staining distal body. Evans and his colleagues, 
(1982) were able to show that this dark-stained body was 
transferred via crossing over from one chromatid of the Y
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to one chromatid of the X during meiosis and the Sxr gene 
was contained within this body. Since X inactivation is a 
random procedure, offspring from XYSxr males could be 
expected to be a mixture of XXSxr females, XXgxr males and 
XXSxr intersexes. This indeed was shown to be the case by 
Cattenach et al (1982), although there appeared to be an 
imbalance towards males. Further research by McLaren and 
Monk, (1982) indicated that when the X chromosome carrying 
the Sxr gene is preferentially inactivated, fertile XXgxr 
females can be produced as a result of the Sxr gene being 
inactivated with its carrier X chromosome. Thus, although 
testicular development takes place in the absence of a Y 
chromosome in the Sxr mouse, these males are always sterile 
as adults, probably due to the XX chromosome composition. 
Shapiro et al. (1982) demonstrated increased serological H-
Y in XYgxr carrier males. xxsxr males are H_Y positive, 
whereas XXSxr» males have testes but are H-Y negative 
(McLaren et al. 1984). This indicates that the H-Y antigen 
is not responsible for the testes-determining factor in 
mice or in man (Simpson et al. 1987), but is located very 
close to the testes-determining gene (Tdy) and may be 
necessary for normal spermatogenesis (Burgoyne et al. 
1986).
A few other regions of the Y chromosome have been 
isolated and sequenced genetically, but so far the exact 
switch which triggers testicular differentiation has not 
been identified; in fact, it has been suggested that the Y 
chromosome acts merely as a switch on a cascade of events
7
leading to testicular differentiation which involves 
autosomal genes as well as the sex chromosomes.
Gonadal differentiation.
The gonadal primordium develops on the coelomic surface 
of the mesonephros and is composed of:-
1) coelomic epithelial cells, which give rise to Sertoli 
cells in males and granulosa cells in females,
2) stromal cells derived from gonadal mesenchyme which form 
the interstitial cells
3) primordial germ cells (PGC's) which migrate into the 
gonad from their original location in the wall of the yolk 
sac endoderm.
The PGCs migrate from the yolk sac via the dorsal 
mesentery of the hind gut to the genital ridge. 
Proliferation of the coelomic epithelial cells occurs 
around the same time as the PGC's are accumulating in the 
gonad. These cells aggregate to form cord-like structures 
which surround the PGC's.
Testicular Differentiation.
The first morphological sign of sexual dimorphism in 
the gonad is the differentiation of the pre-Sertoli cells, 
identified by their abundant clear cytoplasm and their 
aggregation to form testicular cords in the fetal testis 
(Jost & Magre, 1984). Myoid cells form around the 
testicular cords and Leydig cells differentiate within the
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interstitial tissue. Testicular differentiation occurs 
early in development, but varies according to species and 
length of gestation, i.e. day 13 post-coitum in the rat 
(Jost, 1972), day 12 in the mouse (Taketo et al. 1985), day 
10 in the golden hamster (MacKay et al. 1989) and between
the 6th and 7th week in humans. After differentiation, the 
pre-Sertoli cells secrete a protein of molecular weight 
125Kd which acts locally to induce the regression of the 
Mullerian ducts, (primitive female sex ducts) (Josso et al. 
1977) . It has also been suggested that the pre-Sertoli 
cells may induce subsequent development of both the 
peritubular cells and the Leydig cells, but this has yet to 
be demonstrated (McLaren, 1987). Leydig cells secrete 
testosterone, the major androgen responsible for the 
masculinization of the genital tract.
Experimental evidence has indicated that gonadal 
differentiation is not dependent on the presence of germ 
cells as their surgical removal (Zuckerman, 1960), 
destruction (Merchant, 1975), absence or gross reduction 
of numbers due to mutation (Mintz, 1957; McCoshen, 1983), 
does not prevent differentiation taking place. Nor is 
testicular cord formation essential for the development of 
a testis. In in vitro culture conditions, which appear to 
prevent testicular cord formation, Sertoli cells produced 
Mullerian inhibitory substance at the normal time (Magre & 
Jost, 1984); Leydig cells differentiated and were capable 
of steroidogenesis (Patsavoudi et al. 1985).
On arrival in the gonad, primordial germ cells rapidly
increase in number by mitotic division. In males, once the 
optimal number has been reached i.e. 5000 in the mouse, 
further proliferation ceases until puberty. Thereupon the 
germ cells enter meiosis and continue to proliferate by 
meiotic division throughout life. In contrast to this, 
female germ cells proliferate by mitosis, reaching a peak 
of 7,000,000 by the fifth month of development in humans; 
they then enter the first meiotic division and become 
surrounded by a single layer of granulosa cells to form the 
primordial follicles. The majority are then lost by cell 
degeneration and by the age of 7 years numbers have been 
reduced to around 40,000 (Pinkerton et al. 19 61).
Ovarian Differentiation.
Ovarian differentiation occurs later than that of the 
testis, and is characterised by two successive stages. 
Proliferating germ cells first enter meiosis; this is 
followed by the development of follicles around some of the 
germ cells. Byskov, (1978) has suggested that germ cells 
are induced to enter meiosis by a hormone (meiosis-inducing 
substance) produced by the rete ovarii, since they do not 
enter meiosis if cultured in the absence of the rete. 
However, this finding has still not been confirmed. 
MacLaren, (1984) and Francavilla & Zambini, (1985) have 
reported that a factor produced by the testicular cords 
prevents the germ cells from entering meiosis. In contrast 
to testicular development, where testis cord formation
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occurs in the medulla of the gonad, ovarian follicles 
accumulate within the cortex. The cells in the ovary 
develop the capacity to synthesize oestrogen very early in 
development. Although elegant studies by Jost, (1953) 
showed that the ovary, and therefore its hormonal output, 
is not essential for the differentiation of the female 
genital tract, the diameter of the Mullerian duct in 
castrated male or female rabbit fetuses is less than that 
of normal female fetuses. Thus oestrogens may play a role 
in stabilizing the female sex ducts. It is known that the 
fetal ovary develops the ability to aromatize testosterone 
to oestradiol at a very early age (George & Wilson, 1978).
Endocrine function of gonad
The gonads function as endocrine organs both in 
adulthood and during prenatal development. In the male, 
the capacity to produce androgens develops with the 
differentiation of the Leydig cells (Wilson & Siiteri, 
1973) . In humans, proliferation of these cells and the 
concommitant increase in testosterone production coincides 
with the establishment of the male sex ducts, external 
genitalia and the CNS (Bloch, 1979) . Leydig cell numbers 
then decrease, and by week 21 of gestation have reach a low 
level which is maintained postnatally (Bloch, 1964). 
Other mammals show a similar pattern of development (Wilson 
& Siiteri,1973; Noumura et al. 1966). However, in rodents,
where sex differentiation of the CNS occurs very late in 
gestation or early in the postnatal period, there is a peak
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of testosterone production around the time of birth (Pang 
et al.1979; Pang & Tang, 1984). A similar postnatal peak in 
testosterone levels has been reported in human male 
offspring by some investigators (Forest et al. 1975 ;
Forest & Cathiard, 1975; Dawood & Saxena, 1977), but not by 
others (Abramovich & Rowe, 1973; Mizuno et al. 1968 ).
The importance of gonadal secretions during development 
was first recognized by Lillie, (1917) who proposed that 
secretions (hormones) produced by the bovine testes were 
being carried in the blood to their female twin and 
causing virilisation of the genital tract; these 
masculinized females were dubbed freemartins. Castration 
and testosterone replacement experiments by Jost (1953) 
substantiated the proposals of Lillie that testicular 
compounds were responsible for the phenomenon of the 
freemartin. Jost however, also determined that two 
testicular products were required for complete 
masculinization of the female. These are:
1) Mullerian inhibiting substance, required for 
regression of the female sex ducts
2) Testosterone, required for maintenance and development 
of the Wolffian ducts.
By transplantation experiments in rabbits, Jost showed that 
a testis transplanted onto the mesosalpinx resulted in 
I ipsilateral regression of the Mullerian duct.
I
I
i
i
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Internal Reproductive Tract.
Working with the Flanders giant rabbit, Jost (1947) 
castrated fetuses in utero prior to gonadal 
differentiation and noted that, regardless of genetic sex, 
the offspring were born as phenotypic females, with normal 
oviducts, uteri and vaginae. However, he found that if a 
piece of testis was transplanted on to one of the ovaries 
of a fetal rabbit, the reproductive tract ipsilateral to 
the graft would be masculinized.
Prior to differentiation of the internal genitalia, 
both the Wolffian duct (male) and the Mullerian duct 
(female) presumptive tract anlagen are present. Thus the 
reproductive tract is capable of becoming either male or 
female depending on the hormone milieu at the time of 
differentiation. Jost's castration and transplantation 
experiments, coupled with the proposals of Lillie on the 
cause of the freemartin condition, indicate that the testes 
play a crucial role in determining the phenotypic sex of an 
animal. Injections of testosterone into castrated animals 
stabilize the Wolffian duct, but are unable to trigger 
regression of the Mullerian duct. Therefore two testicular 
products are necessary for complete masculinization. 
Nathalie Josso, (1972) isolated the second substance, 
Jost's Mullerian inhibiting substance (MIS), from fetal 
calf testes and identified it as a non-steroidal 125K 
Dalton dimer which caused regression of the Mullerian duct 
in organ culture. MIS is secreted by the pre-Sertoli cells
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immediately on their differentiation, and regression of the 
duct begins almost at the same time as testicular cord 
formation occurs (Blanchard & Josso 1974).
Testosterone is the androgen which is necessary for the 
differentiation of Wolffian ducts to form seminal vesicles, 
vas deferens and epididymis and also for the maturation 
of spermatic tubules (Wilson & Lasnitzki, 1971; Wilson,
1973) . In the rabbit there is continued high testosterone 
production to day 25 post coitum. This correlates well 
with the stabilization of the Wolffian duct which is 
completed by day 24. Similar results have been reported in 
the rat (Noumura et al. 1966) . This is further borne out
by enzyme studies. Thus, 17/3 hydroxysteroid dehydrogenase 
A5,isomerase activity in Leydig cells is indicative of 
testosterone production, and the amount of testosterone 
produced tends to correlate with the temporal sequence of 
Leydig cell proliferation and regression. The increase in 
testosterone production also correlates with the sequence 
of reproductive tract differentiation (Bloch, 1979). 
Initially testicular production of androgens is under 
autonomous control (Wilson et al. 1983). However in vivo
studies have indicated that within a few days, production 
is under the control of LH (Wilson et al. 1983) . This can
be demonstrated experimentally; pituitary destruction 
during gestation results in decreased testis weight and 
activity (Eguchi et al. 1975: Tseng, 1975)
As has been mentioned previously, the ovaries 
apparently have little function in establishing the female
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reproductive tract, as is indicated by its differentiation 
even in their absence. However the ovaries exhibit 
aromatase activity (which converts testosterone to 
oestrogen) very early in development. In fact, rabbit 
ovaries are reported to acquire this capability at the same 
time as the testis becomes capable of producing 
testosterone (Milewich et al. 1977). Again, timing
appears to be important in female reproductive tract 
differentiation; if the Mullerian duct has not been induced 
to regress by MIS at the appropriate time, it stabilizes 
and goes on to form the Fallopian tubes, uterus and upper 
part of the vagina. In contrast, in the absence of 
testosterone, the Wolffian duct will regress.
External genitalia.
Only at a late stage in Wolffian duct stabilization 
do the cells within the duct develop the capacity to 
convert testosterone to 5a-dihydrotestosterone (DHT) 
(Wilson & Lasnitzki, 1971) . However, levels of the enzyme 
responsible for this conversion, 5a-reductase, are 
particularly high in the tissues of the urogenital sinus 
in males prior to differentiation (Manson 1989). These 
tissues differentiate into the prostate, scrotum and penis.
A human genetic deficiency of the enzyme results in male 
pseudohermaphroditism, whereupon the prostate and external 
genitalia are poorly developed and the offspring may not 
be recognised as males. However, at puberty these tissues
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become responsive to testosterone and the individuals 
develop masculine characteristics, ie. penile growth, 
deepening of the voice and increased muscle mass in 
response to the increase in testosterone at this time 
(Imperato-McGinley 1979). This condition can be induced 
experimentally by giving rats 5a-reductase inhibitors over 
the critical period when masculinization of the external 
genitalia takes place (Imperato-McGinley et al. 1985). In
contrast, in the testicular feminization syndrome, the 
tissues of the urogenital system have greatly reduced 
numbers of androgen receptors, or have receptors that are 
in some way defective, and therefore cannot respond to the 
high levels of testosterone produced either during 
development or puberty (Griffin & Durrant, 1982; Mowszowicz 
et al. 1989) . Thus these individuals have testes, but no
male reproductive tract or external genitalia. Such 
individuals are therefore regarded as females and quite 
often it is not until in adulthood, and married, that their 
true gender becomes apparent, e.g. when attending a clinic 
for infertility (Short, 1972 ) . A similar condition has 
been identified in the mouse (Lyon & Hawkes, 1970) and is 
caused by an X-linked disorder. DNA hybridization analyses 
have shown that the gene specifying the androgen receptor 
is localized on the X chromosome in man, rat and mouse 
(Migeon et al. 1981; Chang, Kokontis & Liao, 1988). Thus
while Wolffian duct stabilization is dependent upon 
testosterone, masculinization of the urogenital sinus 
requires conversion of the androgen to dihydrotestosterone.
In the female the genital tubercle (which forms the 
phallus in males) becomes the clitoris, the urethral folds 
become the labia minora while the genital swelling 
differentiates into the labia majora.
The adrenal gland normally produces corticosteroids and 
very small amounts of androgens. However if corticosteroid 
production is abnormally low, under the influence of ACTH 
stimulation from the pituitary the gland increases in size 
to compensate (congenital adrenal hyperplasia). This 
condition, termed the adrenogenital syndrome, results in 
over production of androgens which can result in varying 
degrees of masculinization of the female external genitalia 
e.g. enlargement of the clitoris and fusion of the labia 
(New et al. 1983) . In male offspring this increase in
androgen output can cause precocious puberty (Short, 1972). 
Similar abnormalities have been brought about by treatment 
of pregnant women with synthetic progestins (e.g. 
diethylstilboestrol) to fend off a threatened miscarriage 
(Hayles & Nolan, 1958; Johnson & Everitt, 1988).
Sexual differentiation of the CNS.
Many aspects of CNS function show sex differences. 
These include physiological controls such as gonadotropin 
release, sensory capacities, and many types of social and 
non-social behaviour. This suggests that male and female 
brains differ functionally and/or structurally. Like the 
reproductive tract and genitalia, the immature brain
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appears to be indifferent and to differentiate during 
development according to the presence or absence of 
testosterone or its metabolites. Here androgens are acting 
to organise the CNS and its capacities.
Differentiation of the hvpothalamus-hvpophvseal-qonadal 
axis and sex-typical behaviour.
This section deals with the perinatal establishment of 
adult patterns of hormone release. However, it is 
necessary first to discuss the differences in these 
patterns in the adult mammal. In adulthood, female sex 
hormones are produced both tonically and in a cyclic 
pattern, while male hormones are released tonically 
(Neill, 1972) . In the adult mammal, the hypothalamus 
controls the pattern of hormone secretion from the anterior 
pituitary. The anterior pituitary releases many hormones 
of which three are important in reproduction; these are 
luteinising hormone (LH), follicle stimulating hormone 
(FSH), and prolactin (PRL). Prolactin output is controlled 
by prolactin inhibitory factor (PIF),which is now believed 
to be dopamine (MacLeod, 197 6) . LH and FSH secretion is 
controlled by gonadotrophin releasing hormone (GnRH) 
produced in the hypothalamus. Pulses of GnRH are carried 
via the hypophyseal portal system to the adenohypophysis 
where they stimulate the output of the gonadotrophins. 
These in turn are released into the general circulation and 
carried to their target organs, the gonads. The pulsatile 
secretion of GnRH is controlled by a pulse generator
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located within the medial basal hypothalamus (Knobil,
1974): frequency and amplitude of pulses are modified by
feedback mechanisms (Karsch, 1984). There are three of 
these feedback mechanisms, (see fig.1:2)
1) A long loop:- from the gonad to the hypothalamus and 
anterior pituitary; high levels of circulating gonadal 
hormones act to suppress further gonadotrophin and GnRH 
release.
2) A short loop:- from the anterior pituitary to the 
hypothalamus; LH and FSH suppresses GnRH secretion.
3) An ultra short loop:- in which the hypothalamus acts 
upon itself; high concentrations of GnRH suppress its own 
production.
All three are negative feed-back systems in males, but in 
females the long-loop system can at times be positive. 
Also involved in gonadotrophin release at the hypothalamic 
level are a number of neurotransmitters. Of particular 
interest are the monoamines, noradrenaline (NA), dopamine 
(DA) and serotonin (5HT), the amino acid -aminobutyric 
acid (GABA), and the endogenous opioids, the enkephalins 
and endorphins. Dopamine, as already mentioned, acts as an 
inhibitor of prolactin release. Noradrenaline fibres 
synapse with GABA neurones in the POA; GABA neurones 
synapse with LHRH neurons and are probably inhibitory. It 
is thought that NA may stimulate LHRH release during the 
preovulatory surge by reducing this inhibition (see reviews 
Wilson, 1979; De Vries, 1990). Serotonin appears to play a
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H hypothalamus 
AP anterior pituitary 
PP posterior pituitary 
G gonad
Fig.1:2 Feedback mechanisms of the hypothalamo-pituitary< 
gonadal axis.
1. Long loop feedback.
2. Short loop feedback.
3. Ultra-short loop feedback.
dual role in gonadotrophin regulation, since it has been 
reported to act in an inhibitory manner and to facilitate 
the release of the preovulatory LH surge (see review, 
Wilson 1979) . The endogenous opioids may act either on the 
NA/GABA/GnRH pathway by inhibiting NA release, or directly 
on GnRH cells (Miller et_al, 1985) , as they are reported to 
synapse directly onto these neurones (Leranth et al, 1988).
In the male, LH stimulates the testicular Leydig cells 
to produce testosterone which acts synergistically with FSH 
to stimulate the Sertoli cells and induce spermatogenesis 
(de Kretser,1984). The Leydig cells also produce small 
amounts of oestrogen and high levels of circulating 
testosterone plus oestrogen act via the long-loop system to 
suppress gonadotrophin production. The testosterone acts 
in the medial basal hypothalamus to reduce the frequency of 
GnRH pulses, while oestrogen acts directly on the pituitary 
to lower the amplitude of LH pulses (Karsch, 1984).
In the female, the pattern of reproductive hormone
secretion is more complicated and is linked to the
maturation and release of ripe oocytes, the preparation of 
the uterus for implantation, and the induction of 
appropriate behaviour patterns which maximise the chances 
of copulation and fertilisation. Tonic release of LH 
stimulates the ovarian follicular cells to produce 
androgens and oestrogen. FSH induces the granulosa cells 
to aromatize the testosterone produced in the follicular 
cells to oestradiol (Flowerdew, 1987). Oestradiol in the
general circulation stimulates further release of LH and
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FSH which in turn causes further production of oestrogens 
until the levels reach the threshold at which surges of LH 
FSH and PRL are induced (Neill & Smith, 1974) . It is 
believed that oestrogen acts on the anterior hypothalamus- 
suprachiasmatic nucleus-preoptic area to induce these 
surges (Brown-Grant 1977; Goodman, 1978; Peterson & 
Barraclough, 1989). During the period of oestrogen 
production the ovarian follicles are ripening and preparing 
for the release of the oocytes. The surge of LH at this 
time causes massive swelling of the follicles destined to 
be ruptured (Schwartz, 1969): and leads to atresia of
follicles not destined to ovulate (Greep, 1961). 
Furthermore it promotes the switching from oestrogen 
production to progesterone production (Hori et al. 197 0).
This is followed by the rupture of the follicles; the 
released oocytes are swept into the infundibulum of the 
oviduct prior to fertilization. The cells of the ruptured 
follicle form the corpus luteum and produce progesterone 
which acts on the endometrium to prepare for implantation. 
The high levels of circulating oestrogen and progesterone 
at this time act to induce estrous behaviour in the female 
(Feder et al.1971). In the absence of pregnancy, the 
corpus luteum regresses as another cycle begins.
Environmental factors also play a role in controlling 
gonadatrophin secretion: thus visual, olfactory and tactile 
stimulation can induce increases in GnRH output. 
Experiments with mice revealed that initial exposure to a
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female rapidly increases LH pulses in the male; these 
decreased with time of exposure, but rapidly increased 
again when a new female was placed with the male (Coquelin 
& Bronson 1979). Sheep and deer are seasonal breeders with 
a relatively long gestation and therefore mate in the 
autumn. These species go through periods of anestrus and 
testicular quiescence outwith the breeding season. In such 
animals the pineal gland responds to daylength and 
suppresses GnRH release during the periods of long 
daylength. As daylength shortens, the inhibitory actions 
of the pineal are removed and gonadotrophin and steriod 
production increase (Lincoln, 1984). In some species the 
females are induced ovulators, that is ovulation only 
occurs if copulation has taken place. Rabbits, hares and 
cats are examples of induced ovulators. In these females 
the stimulation of the cervix during copulation triggers 
the release of a surge of gonadotrophin which in turn 
induces ovulation (Sadleir, 1969; Conaway, 1971).
Perinatal sexual differentiation of gonadotrophin 
releasing patterns.
In long gestation species, brain sexual differentiation 
takes place prenatally, while in short gestation mammals, 
it occurs in the early postnatal period (see review 
MacLusky & Naftolin, 1981). In rats the critical period 
runs from late gestation to the early postnatal period, 
while in the hamster sexual differentiation of the CNS 
occurs in the postnatal period only.
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In 1936 Pfeiffer reported a series of experiments in 
rats which indicated that the presence of testes during the
perinatal period is necessary for the masculinization of
the pattern of gonadotrophin release from the pituitary. 
Subsequently many experiments have confirmed that 
masculinization of the rodent brain is controlled by
testicular hormones acting during the early perinatal 
period (Barraclough & Gorski 1961; Harris 1970). There is 
a time limit after which the androgen will be ineffective 
in causing masculinization; a single dose of TP on days 2 
or 5 resulted in 100% anovulatory sterility; on day 10, TP 
caused sterility in some females but not all, while the 
same dose on day 20 had no effect (Barraclough, 1961). Male 
rats castrated on or before day 3 were capable of
sustaining cyclic release of gonadotrophins in adulthood, 
whereas male rats castrated on day 5 postnatally could not 
(Harris, 197 0). However, low doses of testosterone over 
several days postnatally will cause permanent anovulatory 
sterility. Female rats treated in this manner will, at 
puberty, show a few ovulatory cycles and then become 
permanently sterile. This process is termed the delayed 
anovulatory syndrome (Swanson & van der Werff ten Bosch, 
1964).
Administration of various androgenic metabolites led to 
the conclusion that testosterone itself is not responsible 
for male differentiation in those regions of the rat brain 
controlling gonadotrophin release. For complete
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masculinization to occur, testosterone needs to be 
converted to oestradiol-17/? (McDonald & Doughty 1974). 
Oestrogen treatment before day 5 postnatally was shown to 
be as effective as testosterone in causing anovulatory 
sterility in female rats (Gorski, 1963; Dorner et al. 1971; 
Christensen & Gorski, 1978). Similarly antioestrogen 
administration prevents the masculine pattern of 
gonadotrophin release in the androgenized female rat 
(McDonald & Doughty, 1972). Immunocytochemical studies 
reveal large numbers of oestrogenic receptors locat.ed 
within the hypothalamus and other sexually dimorphic areas 
in both male and female rats. (Naftolin et al 197 5; Toran- 
Allerand et al 1980) . Nonetheless, not all CNS sexual 
differentiation is oestrogen-activated; a few areas have a 
high concentration of testosterone receptors and a deficit 
of oestrogen receptors. These regions, e.g. spinal nucleus 
of Bulobcavernosus (SNB) appear to require 5a-reductase 
activity to become committed to their masculine role 
(Breedlove & Arnold, 1983c).
A circulating oestrogen-binding substance a-fetoprotein 
(AFP) is present in high levels in the fetus, neonate and 
pregnant female, but is not found in non-pregnant females 
or adult males (Raynaud et al. 1971). AFP was initially
thought to prevent plasma oestrogens from reacting with the 
intracellular receptors within susceptible areas of the 
brain (MacLusky & Naftolin, 1981). However, contradictory 
evidence has since come to light regarding the function of 
AFP. Steroid-binding proteins, including AFP, transport
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steroids in an inactive form. AFP is not synthesized within 
neurones, but as it has been detected within brain cells 
(Benno & Williams, 1978; Schachter and Toran-Allerand,
1982) it must have been transported there via endocytosis. 
Therefore, AFP does not, as was originally believed, 
prevent oestrogen from reacting with brain cells, but may 
act to control the level of interaction. This would suggest 
that oestrogens may also be required for feminization of 
the brain, since Tamoxifen (an oestrogen antagonist) given 
postnatally to female rats causes permanent anovulatory 
sterility (PAS), and reduces feminine receptivity. However 
it is unable to masculinize sexual behaviour (Dohler et al. 
1976). For masculinization to be completed a combination 
of oestrogen and testosterone may be required. On the 
other hand , perhaps higher levels of oestrogen, (enhanced 
by aromatization of testosterone) , may be necessary before 
masculinization can take place. Such a phenomenon would in 
part explain some of the reported changes in adult sexual 
behaviour. Females exposed to higher levels of oestrogen 
than normal during the perinatal period, show less adult 
feminine sexual behaviour or more masculine sexual 
behaviour than expected, depending on the dosage. 
Similarly, males deprived of threshold levels of oestrogen 
display more feminine and less masculine behaviour than 
expected. Oestradiol has been reported to enhance neuronal 
survival (Toran-Allerand, 1976), induce dendritic
arborization in hypothalamic explants (Toran-Allerand 1984)
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and enhance hypothalamic synaptic formation (Matsumoto & 
Aria 1976) . It is thus possible that by these processes 
oestrogen, depending on the dose, imposes a feminine or 
masculine pattern on the immature developing brain.
Can other androgen metabolites masculinize the brain 
during the critical postnatal period? This seems unlikely 
as DHT administered during the critical postnatal period 
has little or no effect on hormone secretion patterns in 
females or males castrated at birth, neither do other 5a- 
reduced androgens (McDonald & Doughty 1972; Aria, 1972; 
Whalen & Luttge 1971; Tonjes et al 1987).
Sexual differentiation of behaviour.
Many aspects of behaviour are sexually dimorphic; these 
include aggression, courtship and copulation, maternal and 
play behaviour. All of these forms of behaviour require 
perinatal exposure to testicular hormones and /or their 
metabolites to be masculinized. This is demonstrated by 
exposing female neonates to androgens or by castrating 
males on day 1 postnatally. Perinatally androgenized 
female rats display less maternal behaviour in adulthood 
than normal, while neonatally castrated males show more 
maternal behaviour (Quadagno & Rockwell, 1972; Bridges et 
al, 1973). Similarly, female rats exposed to androgens 
during the critical period of differentiation display more 
rough and tumble play (male-typical behaviour) as pups 
(Olioff & Stewart, 1978; Tonjes et al. 1987) and more
aggression as adults (Van de Poll, 1978) than untreated
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females.
Adult sexual behaviour is activated by gonadal hormones 
after puberty. Masculine sexual behaviour patterns (which, 
in the rodent, include sniffing the female, licking the 
vulval region, mounting, intromission and ejaculation) 
require exposure to testicular androgens within the first 
five days of life (Whalen & Edwards, 1967; Paup, Coniglio & 
Clemens, 1972). Absence of androgens during this period 
results in a failure to display these behaviours even when 
androgens are administered in adulthood. Moreover, a 
genetic male deprived of masculinizing hormones during the 
critical period will respond behaviourally to oestrogen and 
progesterone priming in adulthood by displaying feminine 
sexual behaviour (i.e .lordosis) to a normal male. 
Defeminization, that is loss of the ability to display 
feminine copulatory behaviour in adulthood after the 
appropriate priming, also occurs after normal or 
experimental exposure to androgens postnatally in both the 
rat (Whalen & Nadler, 1963) and the golden hamster, (Debold 
& Whalen, 1975). Female hamster pups treated with 
androgens within 5 days of birth are, as adults, capable 
of displaying all parameters of masculine sexual behaviour. 
However, they have a reduced capacity to display feminine 
behaviour (Payne, 1976 & 1979; Debold & Whalen, 1975).
Castration of male pups within 2 days of birth has the 
opposite affect, i.e. it feminizes and demasculinizes adult 
behaviour. Whereas replacement of testosterone at the same
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time prevents this (Whalen & Edwards, 1967; Swanson, 1971). 
Thus, testicular hormones are required for organization of 
the appropriate sexual behaviour patterns. It was 
originally believed that testosterone was responsible for 
masculinization of sexual behaviour, but subsequent studies 
indicate that, in rodents, androgens must be aromatized to 
oestrogens to be effective (Luttge & Whalen, 197 0; Paup, 
Coniglio & Clemens, 1972). Futhermore, antioestrogens such 
as MER25 and Tamoxifen, given concurrently with 
testosterone or oestrogen prevents the masculinisation of 
behaviour (McDonald & Doughty, 1972 ; Dohler et al. 1984c).
Additional studies have shown that masculinization and 
defeminization are two separate processes, and that it is 
possible to masculinize female golden hamsters with 
exogenous androgens without defeminizing them (Payne, 
1979). Defeminization without masculinization can result 
in an animal which responds to neither androgens nor 
oestrogens in adulthood (Dohler et al. 1984c).
The exact location of the areas within the hypothalamus 
which control sexual behaviour have not yet been totally 
elucidated. Pfaff & Sakuma, (1979) and DeJonge et al, 
(1989) reported that masculine sexual behaviour is markedly 
inhibited by lesion in the medial preoptic area of the 
adult rat, and adult gerbil (Commins & Yahr, 1984). On the 
other hand, Hennessey et_ai, (1986) reported that POA 
lesions increased the display of lordosis in adult male 
rats. Feminine sexual behaviour is inhibited by lesion of 
the ventromedial hypothalamus (Malsbury et al, 1977; Pfaff
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& Sakuma, 1979).
The establishment of behavioural patterns during the 
postnatal period is a complex process which probably 
involves neurotransmitters and/or peptides as well as 
gonadal hormones. Of particular interest is the role of 
serotonin (5HT) in this process. In 1970 Ladosky & Gaziri 
reported a temporary sex difference in the levels of 5HT in 
the hypothalamus of the rat on day 12 postnatally. 
Serotonin levels rise in both male and females from birth 
(Schmidt & Saunders-Bush, 1971) but at day 12 females have 
significantly more hypothalamic 5HT than males. Giulian 
et al, (197 3) has suggested that the increased levels of
5HT observed in females results from a greater synthesis, 
while Gaziri & Ladosky, (197 3) argued that the difference 
is due to increased monoamine oxidase activity in males. 
The fact that this sex difference is androgen-dependent 
(Ladosky & Gaziri, 1972) suggests that 5HT may be involved 
in the process of sexual differentiation. Serotonin has 
been implicated in the control of adult sexual behaviour 
(Dewsbury et al. 1972); thus increased 5HT levels reduce
lordosis in female rabbits, hamsters and mice (Meyerson et 
al, 1973), whereas decreased 5HT levels increase lordosis 
(Zelman et al. 1973 , 1977). Perinatal manipulation of
serotonin has been equally effective in altering patterns 
of behaviour in adulthood. Hyyppa et al. (1972) and Wilson
et al. (1986) reported that reduction of 5HT postnatally by
p-chlorophenylalanine (pCPA) subsequently enhances
29
masculine sexual behaviour in adult male rats. In contrast, 
Farabollini et al. (1988) found no difference in male rat
sexual behaviour after perinatal administration of pCPA, 
nor did Johnston et al, (1990) in hamsters. However the
latter authors did find that pCPA given during the second 
week of life increased feminine sexual behaviour in male 
hamsters, while decreasing it in females. This would 
suggest that 5HT may be involved in the defeminization 
process. In contrast, increasing 5HT levels during the 
perinatal period appears to have little effect on feminine 
sexual behaviour in either male or female rats (Gladue et 
al, 1977) . Although NA and DA do not show any apparent 
differences in levels between the sexes during development, 
they have been reported to be involved in the control of 
sexual behaviour in the adult (Agmo & Fernandez, 1989; 
Vathy & Etgen, 1989).
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Differences in CNS morphology.
Male and female brains, while differing slightly in 
size, were always thought to be morphologically similar. 
However, over the past 2 0 years it has become apparent that 
there are sex differences in the morphology of certain 
areas of the mammalian CNS. Listed below are some of 
these.
1. Differences in nuclear and nucleoli size in the medial 
preoptic area, (Dorner & Staudt, 1968) and the ventromedial 
nucleus (Dorner & Staudt, 1969) of the rat. The nuclei and 
nucleoli volumes of the female are greater than those of 
the male.
2. Numbers of dendritic spine synapses of non-strial origin 
in the medial preoptic area of the rat; females have more 
spine synapses than do males (Raisman & Field, 197 3).
3. Organization of synapses in the amygdala of the rat;
there are greater numbers of shaft synapses in the male
than in the female (Nishizuka & Arai, 1981).
4. Dendritic branching patterns in the hamster preoptic
area are sexually dimorphic (Greenough et al.1977).
5. The volume of the sexually dimorphic nucleus of the 
preoptic area is greater in male than in female rats
(Gorski et al. 1978).
6. Male rats have a greater number of both light and dark 
accessory olfactory bulb granule cells than do females, 
neonatal castration of males or female androgenization 
reverses these differences (Segovia et al. 1986).
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7. There is a greater number of motor neurones in the 
spinal nucleus of bulbocavernosus in the male than in the 
female rat, this is determined by postnatal androgen levels 
(Breedlove & Arnold, 1980)
8.The volume of the parastrial nucleus of the rat preoptic 
area is greater in females than in males (del Abril et al. 
1990)
9. The corpus callosum of the male rat is larger than that 
of the female (Fitch et al. 1990).
Of these morphologically different areas, those which have 
been most extensively studied are the sexually dimorphic 
nucleus of the preoptic area (SDN-POA) and the spinal 
nucleus of bulbocavernosus (SNB). These will be dealt 
with in detail since they are examined in this study.
SDN-POA
The preoptic area of the hypothalamus has been shown to 
be important in the organization of adult sexual behaviour 
patterns and in the control of the preovulatory LH surge in 
females (see above). The findings of Dorner & Staudt, 
(1968,1969) that cell body size within the area is sexually 
dimorphic, and the elegant studies by Raisman & Field 
(1973), into the sex differences in the synaptic 
organization of the POA lie at the foundation of a 
considerable accumulation of knowledge over the past 20 
years. Gorski et al * s (1978) finding that the volume of 
the medial preoptic area is greater in male than in female
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adult rats led to this region being named the SDN-POA. 
Further research indicated that this difference in volume 
is under the influence of testicular hormones and that the 
difference becomes manifest during the perinatal period 
(Jacobson et al. 1980). Castration of male rat pups on the 
day of birth and up to 2 4 hours postnatally reduced the 
volume of the adult SDN-POA to approximately 50% of that of 
controls (Handa et al. 1985), but did not wholly sex
reverse it. Administration of TP or EB postnatally to 
females increased the volume, but not to that of control 
males (Gorski et al. 1978). However, if the treatment was 
extended such that it covered both the pre-and postnatal 
period, the volume of the female SDN-POA was increased to a 
size egual to that of normal males (Dohler et al. 1982) .
Since the discovery of the SDN-POA in rats, the same 
structure has been identified in gerbils (Yahr & Commins,
1983), guinea-pig (Hines et al. 1982; Byne & Bleier, 1987), 
hamster and mouse (Bleier et al. 1982), ferret (Tobet et
al, 1986) and man (Swaab & Hofman, 1988).
The neurones which make up the SDN-POA migrate from the 
periventricular area to form the nucleus during gestation. 
Tritiated thymidine can be used to label cells undergoing 
mitosis. By administering this to pregnant rats on day 18 
post-coitum Jacobson et al, (1980) were able to locate
mitotic neurones in the ependyma of the 3rd ventricle and 
follow their migration to the SDN-POA. The number of 
labelled neurones decreased over this period indicating 
cell death, a common feature of CNS development. From
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these observations, and the reports that oestrogens can 
stimulate neuronal survival (Toran-Allerand, 1981) and 
enhance dendritic arborization (Toran-Allerand, 1980), 
Gorski, (1984) suggested that the surge of testicular 
hormones present in male rats on day E18 may promote 
neuronal survival during a period when cell death is taking 
place. It is also of interest to note that 5HT is involved 
in the determining size of the SDN. Handa et al (1986) 
investigated the effects of serotonin depletion on the 
volume of the nucleus and found that pCPA administered from 
day 8 of gestation significantly reduced nuclear size at 
birth. However this change in size is not maintained into 
adulthood (Hines & Gorski, 1986) More recently, Bloch & 
Gorski, (1988) have described the SDN-POA in terms of the 
contribution from each of three specific cytoarchitectonic 
divisions of the medial preoptic nucleus (MPN). The SDN- 
POA is located within the medial area of the MPN (MPNm) 
with contributions from the anteroventral division of the 
MPN (MPNav), the lateral division of the MPN (MPN1) and the 
central division of the MPN (MPNc) . In males the 
contributions from the MPNc and the MPNav are greater while 
in the female the contribution from the other regions of 
the MPN than these two was greater. These findings reveal 
that the SDN-POA has a different cytoarchitectonic 
composition in the two sexes, and that, in the male at 
least since the relative contribution from the MPN, MPN1 
and MPNm is altered by neonatal castration, the input is
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controlled by testicular hormones during development.
SNB
One of the more striking examples of a sexually 
dimorphic area within the CNS is that of the (SNB) , which 
in the rat consists of some 2 00 neurones in males but only 
40 in females. The cells of the SNB form a discrete 
nucleus within the dorsomedial aspect of the ventral horn 
between lumbar regions L5 and SI in the spinal cord. The 
SNB cells are large multipolar motor neurones with 
extensive dendritic arborisation which innervate the 
perineal muscles bulbocavernosus (BC) and levator ani (LA). 
These two striated muscles, together with the 
ischiocavernosus (IC), mediate penile reflexes in the male 
rat (Sachs 1982; Hart & Melese d'Hospital 1983), and mouse 
(Elmore & Sachs 1988) . The BC and LA are attached 
exclusively to the penis, while the IC is attached to the 
penis and ischium. The IC is innervated by a subpopulation 
of motor neurones in the dorsolateral nucleus (DLN), the 
remainder of which innervate the hind limb via the sciatic 
nerve. The SNB is comparable to Onuf's nucleus in the dog 
and in humans.
These motor neurones and their target muscles are known 
to accumulate androgens and are dependent on testosterone 
or DHT for their maintenance (Breedlove & Arnold, 198 3). 
Castration of adult male rats results in decreased size of 
the soma of motor neurones and a reduction of muscle mass, 
but does not reduce the number of SNB neurones (Breedlove &
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Arnold, 1981) . However, in some strains of mice the SNB 
neurone numbers are also reduced (Wee & Clemens, 1987); 
androgen administration prevents this. Autoradiographic 
studies have revealed that all motor neurones in the lumbar 
regions of the rat spinal cord are capable of accumulating 
testosterone and dihydrotestosterone, but not oestrogen 
(Breedlove & Arnold, 1983). Nevertheless, those motor 
neurones involved in specifically masculine functions (e.g. 
SNB) were seen to take up significantly more label than 
those not involved in sexual functions e.g. the retrodorsal 
nucleus (RDLN) which innervates the leg (Breedlove & 
Arnold, 1980). Breedlove and Arnold (1983) repeated these 
autoradiographic experiments in females and reported that 
there is a significant sex difference in androgen uptake, 
male motor neurones accumulating more testosterone than 
those in the female.
Both the muscles and SNB nucleus are dependent upon the 
hormone milieu during the perinatal period for their 
survival. During the prenatal period both sexes develop 
these perineal muscles and the motor neurones which 
innervate them (Cihak et al, 1970; Nordeen et al. 1985).
At birth there is substantial neuronal cell death, but this 
is less in normal males or in females given testosterone or 
DHT on day 2 postnatally than in control females (Nordeen 
et al. 1985) . In untreated females and in androgen-
insensitive mutant (Tfm) males, the motor neurone numbers 
fall to less than one third of those in control males; soma
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size is reduced in the remaining cells and the muscles 
completely disappear (Breedlove & Arnold, 1981). Prenatal 
exposure of males to the anti-androgen flutamide, plus 
neonatal castration, completely sex-reverses the SNB 
(Breedlove & Arnold, 198 3).
Treatment of Sprague-Dawley rat pups postnatally with 
oestradiol does not prevent SNB cell death in females or in 
males castrated at birth (Breedlove et al. 1982). However,
this finding may be due to a strain difference as oestrdiol 
benzoate has been reported to enhance SNB neurone survival 
in female albino Swiss rats (Currie et al, 1990) . Thus it
appears that in some strains this particular nucleus is 
exclusively dependent upon testosterone and/ or its 5a- 
reduced metabolites for its survival, while in others it is 
not.
Exactly how androgens promote the survival of the 
motor neurones and target muscles is not yet fully 
understood. However, it has been shown that testosterone 
will support BC survival in the absence of a neural input 
(Fishman & Breedlove, 1988). Neuromuscular junctions are 
already established before androgen exposure is necessary 
for their survival, therefore androgens are not necessary 
for the initial formation of the junction (Rand & 
Breedlove, 1987) . From these two finding it has been 
suggested that androgens act by stabilizing the muscle and 
thus promote SNB survival via trophic substance released by 
it.
With the exception of gonadal differentiation itself,
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all of the processes of sexual differentiation described 
here have required exposure to testicular androgens for 
masculinization. That animals and humans have been 
reported with ambiguous sexuality demonstrates the 
plasticity and sensitivity of the developing systems. 
Anything, exogenous or endogenous, which interferes with 
androgen synthesis, release or uptake may therefore cause 
incomplete masculinization. In addition, interference with 
the development of those parameters involved in sexual 
differentiation, such as retardation or precocious 
development of neural structures may also result in altered 
sexuality.
Of particular interest, is the effect that exposure to 
opiates during this period of plasticity, might have on the 
sexual differentiation of the CNS.
Opiates.
Opiate-type drug abuse has been widespread throughout 
the world for many years. Unfortunately for the addicts, 
one of the more common side-affects of chronic drug abuse 
is loss of reproductive function. Male addicts report 
loss of libido, failure to sustain erection and failure to 
ejaculate. Ironically, opiates initially heighten sexual 
arousal and were once claimed to be aphrodisiacs, but as 
tolerance builds up, ever higher doses are needed, 
resulting in a progressive decline in sexual function 
(Cushman, 1972; Hanbury, Cohen & Stimmel, 1977; Smith et
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al, 1982) . Female addicts are reported to suffer loss of 
libido, anorgasmia, amenorrhoea and anovulation (see review 
by Pfaus & Gorzalka, 1986). Nonetheless, many women do 
become pregnant, and continue to abuse drugs throughout 
pregnancy. Babies born to opiate abusers suffer the 
classic withdrawal symptoms, 1 Cold Turkey" at birth and 
often have to be weaned gradually off the drug (Harper et 
al, 1977). Follow up assessment of babies exposed to 
opiates during the perinatal period have revealed that 
these children still have poorer motor control and learning 
abilities when compared to infants of similar socio­
economic status 18 months after birth (Rosen & Johnson, 
1982) .
Investigations into how opiates might act to suppress 
reproductive function have shown that heroin administration 
results in a reduction of serum LH levels and a 
concommitant lowering of serum testosterone (Akabori & 
Barraclough, 1986; Purohit et al. 1979 ; Genazzani &
Petraglia, 1989). The action of opiates on LH levels is 
believed to be mediated via inhibition of GnRH release.
The discovery of specific opiate receptors in the 
mammalian CNS (Pert & Snyder, 1973; Terenius, 1973; Simon 
et al. 1973) suggested that there must be endogenous
opiate-like substances produced which would recognise these 
receptors. The enkephalins were the first of these 
endogenous substances to be reported, (Hughes, (1975) and 
Hughes et al. (1975) . Subsequently, /3-endorphin, a 31-
amino-acid peptide was isolated by Li & Chung (1976), and
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was shown to have potent morphine-like activity both in- 
vivo and in-vitro. Since then many more opiate-like 
peptides have been isolated and characterised. To avoid 
confusion between the exogenous opiates and the endogenous 
opiate-like peptides, the endogenous peptides are referred 
to as the opioids. The roles that these substances play 
within the body are many and varied. They are reported to 
be involved in regulation of gonadotropin release (Diez- 
Guerra et al. 1986; Gilbeau et al. 1984; Dyer et al. 1988), 
sexual behaviour (Pfaus & Gorzalka, 1986), respiration 
(Hindmarsh & Sankaran, 1985), gastrointestinal activity 
(Kreek et al. 1983 ) and modulation of pain sensation
(Bausbaum & Fields, 1984). In addition, opioids have been 
shown to be active during development in the regulation of 
cell proliferation (Zagon & McLaughlin,1987) and synaptic 
organization (Hauser et al, 1987). Since exogenous
opiates are known to alter the ontogeny of opiate receptors 
during development (Hammer et al, 1989) it would be very
surprising if in doing so, they did not also interfere with 
the role of the endogenous opioids in neural development.
The identification of opiate receptors and opioid 
neural systems within the hypothalamus suggested a role for 
these in the control of reproduction (Kornblum et al. 1987; 
Martini et al. 1989). That opiates inhibited LH release
and sexual behaviour lent support to this theory. 
Furthermore the administration of the opiate antagonist 
naloxone or the more potent naltrexone reversed the
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inhibitory effects of morphine on sexual behaviour and 
gonadotrophin release. In addition, naloxone enhanced 
sexual behaviour in the absence of opiate drugs (Pfaus & 
Gorzalka, 1987; Murphy, 1981).
Opiate receptors have been separated into the sub- 
types, /x, <5 and k, according to the types of opiate/opioid 
which bind to them. Morphine binds to both ji and S 
receptors but is 50 times more potent at the /x-receptor, 
the enkephalins also bind preferably to the yu. receptor. (3- 
endorphin binds with equal affinity to both /x and S 
receptors while dynorphin binds to k receptors 
Investigations into the ontogeny of the opioid receptors 
have revealed that they are first detectable within the rat 
CNS on embryonic day 14 (Kent et al, 1982) and in the human 
brain by week 20 of gestation (Magnan et al. 1988; Magnan & 
Tiberi, 1989). The early development of these receptors 
and the fact that their patterns of distribution change 
with time (Tavani et al. 1985 ; Petrillo et al, 1987)
suggests that they may play a vital role in development. 
Equally interesting is the finding that receptor 
concentration is altered by manipulation of gonadal 
hormones in the adult (Hahn & Fishman, 1979) and neonatal 
rat (Hammer, 1985). Further reports have indicated that 
exposure to morphine during the developmental period alters 
receptor distribution and density (Tsang & Ng, 1980; 
Tempel et al. 1988) , and inhibits both DNA synthesis in
vivo (Kornblum et al. 1987) and neuronal outgrowth in vitro 
(Davila-Garcia & Azmitia, 1989).
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Opioids act as neurotransmitters to inhibit or 
activate other neurones, and are known to block LH 
secretion by inhibiting noradrenergic transmission in the 
preoptic area (Dyer et al. 1988; Gopalan et al. 1989).
The potent opiate antagonist naloxone, has the opposite 
effect in that it amplifies LH release (Van Vugt et al. 
1982). Because opiates apparently play a marked role in 
development, and reduce androgen levels in both adults (see 
above) and neonates (Ward et al. 1983) it is likely that
exposure to such drugs during the critical period of sexual 
differentiation, would be detrimental to the 
masculinization of the rodent CNS. This project therefore 
set out firstly to examine the changes (if any) in the 
adult sexual behaviour of golden hamsters exposed to a 
long-acting form of morphine (Duromorph) over the perinatal 
period. If changes were observed to occur, a second aim 
was to examine other an over the perinatal period
>iogy). ‘V i'- O'. 5 iroT-\ t
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Appendix 1
All of the experiments discussed in this thesis involve 
the administration of morphine to pregnant females and/or 
their pups. Handling of animals is stressful to them. 
This, therefore had to be minimized to avoid the effects of 
stress interfering with the action of the drug. Therefore 
a long-acting form of morphine, Duromorph, was chosen for 
these experiments. Treatment was reduced to a maximum of 
two injections per day using Duromorph. Duromorph is a 
long-acting aqueous suspension of morphine of which 95% is 
in crystaline form. Before the experiments were begun, it 
was important to establish that
a) the drug was effective and
b) that it was indeed long-acting.
Three experiments were carried out to establish that 
Duromorph was suitable for use in this investigation. 
These experiments were not carried out by the author, but 
by other members of staff as part of a pilot study, prior 
to the main investigation. Two studies compared Duromorph 
with morphine sulphate to determine how long the drug was 
effective.
i) The first experiment compared the analgesic 
effects of the two drugs using a standard hot-plate test. 
This test was carried out in the Anatomy Dept by Mrs. J 
Odber (Psychology). The results from the tests (shown in 
appendix 1:1) demonstrate that while both forms of morphine 
rapidly caused analgesia, the effects of morphine sulphate 
were short-term and the response latency to the heat was
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almost back to control levels within two hours of 
administration. In contrast, Duromorph treated animals 
continued to display analgesic effects 12 hours after 
treatment, ii) This experiment and the following one, 
were carried out in the Department of Materia Medica, 
Western Infirmary, Glasgow by Mr.G Forrest.
Pregnant female hamsters were treated with Duromorph 
and culled at various times after treatment. Blood was 
removed and the serum analysed chromatographically using 
High Performance Liquid Chromatography coupled to a U.V. 
detector. Concentrations of morphine and its metabolites 
Morphine-6-glucuronate (M-6-G) and morphine-3-glucuronate 
(M-3-G) were measured (see appendix 1:2).
The concentrations of both morphine and its inactive 
metabolite M-3-G decline fairly quickly from the blood 
while the active metabolite M-6-G [known to be x 2 0 more 
potent than morphine itself (Pasternak et al. 1987) was
still present in the blood 24 hours after administration, 
iii) Further chromatographic analyses of the
concentrations of the drugs in brain tissue of mothers and 
of fetuses were carried out (see appendix 1:3). These 
investigations indicated that morphine does cross the 
placental barrier and accumulates in the fetal brain to a 
greater extent than in the adult.
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A p p e n d i x  1:1
Hot Plate test Temp. 45.2 °C
Time from treatment response latency n
co n tro l 11.4 + 1.3 3 0
morphine sulphate 
1 5m ins
19.4 ±3.5 8
30 mins 35.1 + 0.8 ** 6
1 hour 48.6 + 5.0 ** 6
2 hours 19.5 + 3.3 5
duromorph 30 mins 26.1 + 5.5 ** 10
1 hour 30.6 + 3.5 ** 1 1
4 hours 32.8 ±  4.6 ** 12
6 hours 32.7 + 4.6 ** 1 1
8 hours 20.9 + 2.8 * 8
12 hours 24.8 + 4.5 ** 6
24 hours 17.4 + 3.1 6
Latency of response to the hot plate in hamsters treated 
with morphine sulphate or Duromorph.
Mean seconds + SEM
* differs from controls p<0.05 
** differs from controls p<0.01
A p p e n d i x  1:2
Plasma Concentrations of morphine and its metabolites.
Time after 
in je c t io n
m orphine M-3-G M-6-G
30 mins 4893 21076 436
1 hour 451 8078 261
3 hours 233 4082 364
5 hours 78 1549 928
8 hours 31 605 68
24 hours .. . 30 87
1:2 Plasma levels of morphine and its metabolites, 
m o rp h in e -3 -g lu c u ro n a te  (M -3 -G ) and m o rp h in e -6 -  
glucuronate (M-6-G) (ng/ml) after duromorph (lOmg/kg) 
in jec tion .
A ppendix  1:3
Concentrations of morphine and its metabolites
n m orphine M-3-G M-6-G
ad u lt
p lasm a
5 0.18 + 0.2 6.47 + 4.9 0
adu lt
b ra in
5 1.03 ± 3.8 0.31 ±0.35 0.84 ±0.5
fetal brain 5 3.7 ± 2.2 3.62 ±3.2 0
1:3 Levels of morphine and its metabolites in adult 
female plasma and brain and in fetal brain (jug/ml)
Chapter 2
The effects of perinatal opiate administration on the 
differentiation of sexual behaviour patterns.
Whalen & Edwards (19 67) showed that if male rodents 
are castrated at birth, they are unable to display the 
normal patterns of male sexual behaviour after appropriate 
androgen priming in adulthood. However, if the same or 
similarly-treated males are primed with oestrogen and 
progesterone they will display the feminine lordotic 
posture when placed with a stud male. In contrast, female 
rats or hamsters, given a single injection of testosterone 
or TP before day 5 postnatally, display reduced amounts 
of feminine behaviour as adults and exhibit all aspects of 
masculine copulatory behaviour when placed with an 
oestrous female (Paup et al. 1972; Payne, 1979). These
results demonstrate that masculinization and defeminization 
of adult sexual behaviour require exposure to testicular 
hormones during the early postnatal period.
Analysis of androgen levels during development have 
revealed that there is a surge of testosterone which 
corresponds to the period of masculinization of 
reproductive tract and genitalia in mammals (Warren et 
al, 1973) . In addition, in the rat, there is a significant 
rise in testosterone during embryonic days 18 and 19 (Weisz 
& Ward, 1980) and on the day of birth (Slob et al. 1980).
It appears that these two androgen peaks are related to 
masculinization of the CNS and that both are necessary for
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complete masculinization. The E18-19 peak seems to prime 
the CNS and enable it to react to the later postnatal surge 
of androgen (Perakis & Stylianopoulou, 1986). Altering the 
timing of the late gestational surge of testosterone 
results in males which show a decrease in masculine, and an 
increase in feminine, sexual behaviour. Maternal stress 
during the last week of pregnancy in rats has been shown to 
cause a premature surge of testosterone, such that it 
appears on day E17 and levels of the androgen decline over 
days 18-19 (Ward & Weisz, 1980). It has been suggested 
that such stress causes an increase in /3-endorphin (an 
endogenous opioid) in the mother and/or the pups, and that 
this suppresses LH release in the pups leading to the 
feminization of behaviour (Ward, Orth & Weisz, 1983; Ward & 
Ward, 1985). Evidence for this is that,
1 If naltrexone (an opiate antagonist) is given prior to 
episodes of stress, no feminization of adult behaviour is 
reported in male pups born to these mothers (Ward et al. 
1986) .
2 If exogenous opiates are given to pregnant females over 
the same period, their male offspring show similar 
feminization of adult behaviour to those prenatally 
stressed (Ward, et al. 1983).
Prenatal stress has also been reported to have adverse 
effects on reproductive function in female rats and mice. 
Although it did not appear to affect sexual behaviour per 
se, prenatal stress resulted in changes to the oestrous
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cycle, (Herrenkohl & Politch, 1978; Harvey & Chevins, 1987) 
and reduced fertility and fecundity in female offspring 
(Herrenkohl, 1979). In other studies prenatal exposure to 
morphine sulphate from day 5 to day 12 of gestation did 
significantly reduce both the quality and quantity of 
adult proceptive and receptive behaviour in female rats 
(Vathy et al. 1983). On the other hand, postnatal exposure 
to the opiate antagonist naltrexone significantly enhanced 
lordosis response in adult female rats, but did not affect 
mounting behaviour in males (Meyerson et al. 1988).
The results discussed above suggest that the 
endogenous opioids may be involved in the establishment of 
copulutory behaviour patterns, both pre- and postnatally. 
Therefore, administration of exogenous opiates during this 
critical period may well interfere with the sexual 
differentiation of behaviour.
Studies of Adult Sexual Behaviour
The golden hamster Mesocricetus auratus Waterhouse, was 
used in these studies because adult sexual behaviour in 
this species is almost sexually exclusive. Adult males 
show very little feminine sexual behaviour while normal 
adult females display long bouts of lordosis, the receptive 
posture, and seldom if ever display any masculine sexual 
behaviour (Tiefer, 1970).
Initially experiments were undertaken to determine 
whether morphine given over different times during the 
critical period would have any effect on sexual behaviour,
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and then, would chronic administration of the opiate 
enhance or suppress the effect.
Five treatment groups were established. These were:-
1 Duromorph given pre + postnatally ( n=18 females, 2 6 
males)
2 Duromorph given prenatally only (n=19 females, 18 males)
3 Duromorph given postnatally only (n=28 females, 25
males)
4 Duromorph given prior to mating, throughout pregnancy
and in decreasing amounts during lactation (i.e. chronic 
administration) (n=13 females, 10 males)
5 Untreated controls, virgin males and females housed and 
treated in a similar manner to the experimental animals 
from birth (n=15 females, 19 males)
Materials and methods
All animals were kept in an air-conditioned light reversal 
room, 9 hours dull red light and 15 hours bright light. 
Female hamsters were placed with vigorous stud males for 2- 
3 hours on the afternoon of oestrus. The day of mating was 
taken as day 0. Gestation in hamsters lasts 16 days. 
After mating the females were housed individually in PVC 
cages measuring 26 x 24 x 10 cm and allowed access to food 
and water ad libitum.
Treatments
Pre + Postnatal
1. Duromorph (lOmg/kg) was administered i.p. twice daily to
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females from day 13 of pregnancy until parturition.
Pups were treated similarly from the day of birth for 
four days.
Prenatal only
2. Duromorph (lOmg/kg) i.p. twice daily to females from day 
13 of pregnancy until parturition.
Postnatal only
3. Duromorph (lOmg/kg) i.p. twice daily to pups from day of 
birth for four days.
Chronic
4. Females in oestrus were treated once daily with 
Duromorph (lOmg/kg) i.p. four days prior to mating and 
then throughout pregnancy. They were gradually weaned 
off the opiate during lactation with the dose being 
reduced by approximately 10% per day.
The pups remained with their natural mothers until 
weaned at day 21. They were then sexed and housed with 
same sex litter-mates, 3-4 per cage under reversed lighting 
conditions. At 3 months of age, they were gonadectomised 
under sodium pentabarbitone anaesthesia (Sagatal). The 
testes, epididymides and seminal vesicles were removed from 
the males and the ovaries from the females. After a 
recovery period of three weeks, each animal received a 
subcutaneous injection of oestradiol benzoate (OB) (5jiig) 
dissolved in peanut oil. Twenty-four hours later 500jiig 
progesterone (Prog) was administered sc. in peanut oil. 
Four to six hours after the second injection, each animal
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was tested for its ability to display feminine sexual 
behaviour when placed with a vigorous stud male.
Sexual behaviour of a receptive female hamster consists 
of a depression of the back, with the head and tail raised 
(lordosis), see fig 2:1. A normal female will remain in 
this position between successive mounts and dismounts by 
the males, and may remain so throughout the test period. 
Each test period lasted for 10 minutes.
The tests were carried out in a plexiglass cage 
measuring 3 8 x 2 4 x 16 cm in a room with normal lighting. 
Previous studies have shown that, although the test is 
carried out during the dark period, the animals are 
undisturbed by the bright conditions. Each test session 
was recorded on video using an overhead camera, and the 
information stored for later analysis.
This first test was merely to acclimatise the animals 
to the test conditions. Although data were recorded, they 
were not used in the subsequent analyses. A second test 
was carried out one week later after a second priming with
0.B. and Prog. The data collected during this test are 
reported below. Those aspects of behaviour used in the 
analysis were as follows
1. The latency to lordosis (seconds)
2. The total time spent during the test session in
lordosis (seconds)
3. The longest single episode of lordosis (seconds) 
Following the second test for feminine behaviour, each
animal was given s.c. injections of testosterone
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propionate (TP) (1.5mg thrice weekly) for four weeks. 
They were then tested on three consecutive days for their 
ability to display masculine sexual behaviour towards a 
receptive female.
In the hamster, masculine sexual behaviour consists
of: -
1. Licking and sniffing the female's vulval region.
2. Mounting the female and palpating her flanks with his
forepaws.
3. Intromission, the penetration of the vagina with the 
penis.
4. Self grooming of his own genitalia after each mount.
5. Ejaculation, which occurs after several mounts with 
intromission.
These behaviours are shown in figs 2:1-2:4
The test period lasted for ten minutes on each day. As 
with female behaviour, tests were recorded on video and the 
specific aspects of behaviour used for analysis were as 
follows:-
1. Latency to mount (secs, average for three tests)
2. Total number of mounts (regardless of orientation) over 
the three test periods.
3. Total number of genital self - grooms from the three
tests.
4. Total number of intromissions from three tests.
Statistics
Data were analysed by one-way ANOVA followed by inter-
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group comparisons using Least Significant Difference 
computations. In Expt 1. the chronically-treated groups 
were each compared with controls using Student's t-test.
Results; 
Feminine Sexual Behaviour in Perinatallv - treated Hamsters
Females: (See Table 2:1 Fig.2:5)
Control females adopt the lordotic stance within 60 
seconds of being placed with a stud male, and remain in 
that position for most of the test period. Exposure to 
morphine had little effect on the females' ability to 
display typical receptive behaviour. However, exposure to 
morphine prenatally significantly increased the latency to 
lordosis; and while it reduced both the total and maximum 
length of lordosis; these did not reach significance.
Males: (See Table 2:2 Fig 2:6)
In comparison to females, normal male hamsters show 
little feminine sexual behaviour; only 53% of controls 
displayed any lordosis and even then the duration was 
relatively low. However, exposure to morphine
significantly increased the amount of feminine behaviour 
displayed by males. Of those treated postnatally, 88% 
showed feminine copulatory behaviour and 92% of those 
treated pre + postnatally did so. Pre + postnatal morphine 
exposure significantly decreased latency and increased the 
total length of lordosis displayed by males. Postnatal
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treatment alone also decreased lordosis latency, but did 
not increase the total amount of lordosis, while prenatal 
morphine exposure was ineffective.
Masculine Sexual Behaviour in Perinatallv-treated hamsters.
Females: (See Table 2:3, Fig. 2:7)
There were no significant differences between morphine- 
treated animals and controls in their ability to display 
masculine sexual behaviour.
Males: (See Table 2:4, Fig.2:8)
All of the control males (100%) showed mounting behaviour; 
morphine exposure had little effect on masculine sexual 
behaviour in males. Although there was a slight decrease 
in the numbers of males mounting in the pre + postnatally- 
treated and in the postnatally-treated groups, this was not 
significant. Nor were there any significant differences in 
any other aspect of masculine behaviour in the morphine- 
treated groups.
Sexual behaviour as displayed by hamsters chronically 
exposed to morphine during development. 
Feminine behaviour
Females (See Table 2:5, Fig. 2:9)
As with those acutely exposed to morphine during the 
critical perinatal period (see above), chronically-treated 
females showed no significant change in their ability to
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display feminine sexual behaviour.
Males (See Table 2:6, Fig. 2:10)
Males chronically exposed to morphine showed a 
significantly reduced latency to lordosis. Although total 
and maximum periods of lordosis were increased, these did 
not reach significance.
Masculine Sexual Behaviour
Females (See Table 2:7, Fig 2:11)
Chronic morphine treatment had no effect on the females' 
ability to display masculine sexual behaviour.
Males (See Table 2:8, Fig. 2:12)
In contrast to males treated acutely with morphine, those 
exposed throughout development showed a surprising and 
marked increase in their masculine sexual behaviour. All 
aspects of male copulatory behaviour were significantly 
enhanced by chronic exposure to morphine during gestation.
Discussion
Females seem to be least affected by exposure to 
opiates during the period of sexual differentiation. 
Prenatal exposure to morphine did significantly increase 
latency to lordosis and slightly decrease the total time 
spent in lordosis. This may suggest that opiate exposure 
during this period has interfered with the mechanisms 
involved with response. That the total time spent in
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lordosis was decreased is probably due to the delay in the 
females response to the advances of the male. In
contrast, prenatal opiate exposure has little effect on the 
ability of the male hamster to display feminine sexual 
behaviour, although it appears to have enhanced some 
aspects of masculine sexual behaviour such as intromission 
scores. This is contrary to the findings in rats, where 
prenatal morphine exposure has a marked effect on both 
feminization and demasculinization of males (Ward, Orth & 
Weisz, 1983). Since prenatal manipulation of androgens has 
little effect in the golden hamster (Nucci & Beach, 1971) 
the present findings would suggest that the opiates are 
acting on some other factor (eg the amines), or perhaps 
general neural development to produce these effects.
Pre + postnatal and postnatal morphine administration 
exerted no apparent changes in the males ability to display 
mounting when placed with a receptive female. However both 
treatments have interfered with the defemininzation 
process, such that these males show significantly reduced 
latency to lordosis and more time in lordosis compared to 
controls. In addition, the number of males in each 
treatment group displaying lordosis was increased from 53% 
in controls to 92% and 88% in the pre + post and postnatal 
groups respectively. With regard to the changes in 
behaviour in males the present findings suggest that, in 
the golden hamster, the defeminization process occurs, [or 
is at least most sensitive to manipulation] postnatally. 
However, extending manipulation to cover the late prenatal
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and early postnatal period results in a less defeminized 
male.
Morphine given to females prior to and throughout 
pregnancy had a different effect on their offspring. 
Chronic exposure to morphine during development appears to 
have had no significant effect on either masculine or 
feminine sexual behaviour in females. In contrast, in 
males, the changes are more marked and more surprising! 
Feminine sexual behaviour was increased but only lordosis 
latency was significantly reduced. The number of males 
displaying lordosis and the total amount of lordosis were 
increased but not significantly. On the other hand, 
masculine sexual behaviour in males chronically exposed to 
morphine was most significantly enhanced when compared with 
that of controls. Why this should be so is unknown, but 
it does suggest that long-term exposure to opiates, ie 
throughout gestation and lactation, is less detrimental to 
the developing male than is acute exposure. On the other 
hand it is possible that the findings recorded after acute 
exposure are caused by withdrawal of that drug rather than 
by the drug itself. Lichtblau & Sparber (1984) published a 
review on the effects of opiates during development, and 
are very critical of conclusions drawn from work involving 
short-term exposure, suggesting that opiate withdrawal is 
as harmful, if not more so, than the drug itself.
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Fig.2:1 Male licking the perineal area of a receptive female. 
Female in lordosis.
Fig.2:2 Male mounting a receptive female.
Fig.2:3 Intromission
Fig.2:4 Male self grooming after last mount.
Female remaining in lordosis between mounts.
Experiment  1:
Fem inine Sexual Behaviour in the Adult Golden Hamster.
Female
t r e a tm e n t prenatal
morphine
pre+post
morphine
po s tn a ta l
morphine
control F
value
n 19 18 28 15
lo rdos is
la tency
145+48
**
13+3 73+26 25+4 3.79
p<0.01
to ta l  
lo rdos i  s
365+46 498+15 445+35 431+44 1.62
n.s.
maximum
lordos is
264+44 256+27 298+38 322+60 0.45
n.s.
% showing 
behaviour
89% 100% 96% 100%
Table 2:1. Female hamsters treated perinatally with morphine.
Males
t r e a tm e n t p ren a ta l
morphine
pre & post 
morphine
p os tna ta l
morphine
control F value
n 18 26 25 19
lo rd os is
la tency
360+61 123+33 
* *
187+43
* *
360+60 6.45
p<0.01
to ta l
lo rdos is
76+27 165+25 
* *
126+22 76+23 3.36
p<0.02
maximum
lordos is
26+9 47+8 42+7 28+8 1.64
n.s.
% showing 
behaviour
50% 92% 88% 53%
Table 2:2 Male hamsters treated perinatally with morphine. 
Mean scores in seconds +SEM.
** differs from controls p<0.01
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Experiment  1:
Masculine Sexual Behaviour in the Adult Golden Hamster.
Females
t r e a tm e n t prena ta l
morphine
pre & post 
morphine
pos tna ta l
morphine
control F value
n 18 18 27 12
mount
la tency
592+30 597+6 586+7 574+12 1.66
n.s.
to ta l
mounts
0 0 0 1 2.33
n.s.
t o t a l
grooms
0 0 0 1 1.16
n.s.
t o t a l
i n t ro m i t
0 0 0 0 0 n.s.
% showing 
mounting
11% 11% 15% 40%
Table 2:3. Females treated perinatally with morphine.
Mount latency average latency over three tests, group mean 
in seconds + SEM:
All other parameters, total count over three tests. Group 
means + SEM
Males
t r e a t m e n t prenatal
morphine
pre & post 
morphine
p os tn a ta l
morphine
control F value
n 18 25 25 17
mount
la tency
352+32 434+18 381+29 369+26 1.79:
n.s.
t o t a l
mounts
27+5 14+3 22+4 15+2 2.83:
p<0.04
t o ta l
grooms
23+5
*
10+2 17+3 10+2 4.04
p<0.01
t o t a l
i n t ro m i t
16+4
* *
3+1 9+3 3+1 6.62:
p<0.01
% showing 
behaviour
100% 9 2 % 92% 1 0 0%
Table 2:4. Male hamsters treated perinatally with morphine. 
Scores: As in Table 2:3
* Differs from control p<0.05 
** Differs from controls p<0.01
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E xper im en t  1:
Feminine sexual behaviour in the adult  Golden 
H am ste r  born to mothers exposed to m orph ine  
p r io r  to and throughout  pregnancy and into
l a c t a t i o n .
Fem ales
T rea tm en t n lordosis
latency
total
lordosis
m axim um
lordosis
%
showing
lordosis
con tro l 15 25+4 431+43 322+60 100%
chronic 13 117+60 380+63 263+58 92%
t value 1.65 n.s. 0.68 n.s. 0.70 n.s.
Table 2:5 Females exposed throughout development to 
morphine. Scores in seconds Group mean + SEM
Males
T rea tm en t n lordosis
latency
total
lordosis
m axim um
lordosis
%
showing
lordosis
c on tro l 19 360+60 76+23 28+8 53%
chronic 10 118+55 163+46 43 + 14 90%
t value 2.62
p<0.01
1.88 n.s. 0.98 n.s.
Table 2:6 Feminine sexual behaviour as displayed by adult 
male hamsters exposed throughout development to 
morphine.
Scores in seconds. Group means + SEM.
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Fe m i n i n e  s e x u a l  b e h a v i o u r  in t h e  G o l d e n  H a m s t e r
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9 Fem ales lordosislatency
to ta l
lordosis
1 5 0  control female 
1 3 ^  chronic female
maximum
lordosis
500
400
300
200
100
maximumlordosis to ta l
1 ^ □  control male 
10 □  chronic male
latency lordosis lordosis
Fig. 2: 10 Males * *  differs from con tro ls  p<0.01
E x p e r im en t  1
Mascul ine  sexual behaviour in adult  Golden
Ham sters  born  to mothers exposed to morphine
POPr to, and throughout  pregnancy and into
l a c t a t i o n .
Females
t rea tm en t n mount
latency
total
mounts
total
grooms
total
in t ro s
%
showing
behaviour
contro l 1 2 574+12 1 1 0 50%
chronic 1 3 568+13 1 1 0 54%
t value 0.4 n.s. 0.55
n.s.
1.03
n.s.
0
Table 2:7 Masculine sexual behaviour as displayed by adult 
female hamsters exposed to morphine throughout development.
Mount latency = average over 3 tests in seconds. Other scores 
total scores over three test periods, group mean + SEM
Males
t re a tm e n t n mount
latency
total
mounts
to ta l
grooms
to ta l
in t ro s
% showing 
behaviour
control 17 377+27 14+2 10+2 2+1 100%
chronic 10 266+47 45 + 10 43+10 27+7 100%
t value 2.32
p<0.03
3.94
p<0.01
4.35
p<0.01
4.55
p<0.01
Table 2:8 Masculine sexual behaviour as displayed by adult male 
hamsters exposed to morphine throughout development.
Mount latency = average over 3 tests in seconds.
Other scores are totals over three test periods.
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Experiment 2 
Does testosterone counteract the effect of perinatal 
opiate exposure?
Having found that perinatal morphine exposure does 
affect the adult sexual behaviour of hamsters, further 
investigations were set up to determine whether alterations 
caused by morphine exposure could be counteracted by 
concurrent administration of testosterone. The reasoning 
behind this was that it has been reported that morphine 
reduces testosterone levels, and that if that is the cause 
of the behavioural changes then testosterone administration 
should prevent these changes occuring.
The following experimental groups were set up:- 
Prenatal
1. Duromorph (lOmg/kg) ip twice + 500/xg testosterone sc 
once daily were given to females from day 13 of 
pregnancy to day of parturition. (n=6 females, 14 males)
Pre + postnatal
2. Duromorph (lOmg/kg) ip twice + 500/xg testosterone sc 
once daily were given to females from day 13 of 
pregnancy to day of parturition. In addition, lOmg/kg 
Duromorph ip was given twice daily to pups from the day 
of birth for 4 days. (n=16 females, 15 males)
Postnatal
3. Duromorph (lOmg/kg) ip twice + 100/zg testosterone sc 
once daily were given to pups from the day of birth for 
4 days.(n=10 females, 17 males)
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All other conditions, treatments and behavioural tests 
were as in Expt. 1. in particular, all animals were tested 
for feminine and masculine sexual behaviour as adults.
Results: 
Feminine Sexual Behaviour
Females (See Table 2:9 and Fig.2:13)
In Expt 1 it was shown that perinatal morphine 
administration increased lordosis latency in adulthood. 
This effect was reversed by concurrent perinatal 
testosterone administration. The maximum single episode 
of lordosis was significantly reduced in both the prenatal 
morphine + T and pre + postnatally morphine + T groups, but 
neither lordosis latency nor total lordosis in these two 
groups differed significantly from controls. In contrast, 
concurrent administration of T with morphine postnatally 
significantly reduced feminine sexual behaviour, resulting 
in increased lordosis latency and decreased total and 
maximum lordosis.
Males: (See Table 2:10, Fig. 2:14)
Concurrent administration of testosterone with morphine 
had a more marked affect on feminine behaviour in males. 
In the prenatally-treated group, males injected with both 
morphine and testosterone did not show less feminine sexual 
behaviour than did males treated with morphine alone. In 
contrast, testosterone given with morphine either pre + 
postnatally or postnatally only, significantly reduced the
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amount of feminine sexual behaviour in males. In addition, 
fewer males in the latter 2 groups displayed feminine 
behaviour, 35% in each compared with 92% treated with 
morphine pre + postnatally and 88% treated with morphine 
postnatally.
Masculine Sexual Behaviour
Females: (See Table 2:11, Fig.2:15)
Masculine sexual behaviour was increased in all treatment 
groups given testosterone, and the number of females in ech 
group displaying mounting behaviour was also significantly 
increased. Postnatal morphine + T had the most marked 
effect in that all females in this group mounted. Mount 
latency was reduced and the total number of mounts was 
significantly increased.
Males: (See Table 2:12, Fig.16)
Males treated prenatally and pre + postnatally with 
morphine and testosterone showed significantly more 
masculine sexual behaviour than did males treated with 
morphine only over the same periods. Postnatal morphine + 
testosterone did not alter sexual behaviour when compared 
with morphine only. However, testosterone treatment over 
all three periods enhanced intromission scores when 
compared with controls, although in the case of postnatal 
testosterone it was not significant.
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Discussion
Morphine + testosterone treatment during the perinatal 
period does affect feminine sexual behaviour in females 
when compared with controls, but the timing of treatment 
appears to be an important factor. Although latency to 
lordosis is increased in all groups, only postnatal 
testosterone and morphine caused a significant increase in 
latency when compared to the administration of morphine 
only. Similarly, females treated with morphine + T showed 
less lordosis in total, and the maximum single episode of 
lordotic behaviour was also reduced. These behavioural 
changes which were recorded in the postnatally treated 
groups are most likely to have been caused by the androgen 
rather than the opiate, and are in agreement with many 
other reports that postnatal androgen administration 
reduces feminine sexual behaviour in the rodent (Debold & 
Whalen,1975; Payne, 1976; Goy & McEwen, 1980).
Testosterone given concurrently with morphine pre + 
postnatally and postnatally reversed the feminizing effects 
of morphine on the males1 ability to display lordosis and 
reduced the number of males displaying feminine sexual 
behaviour. Surprisingly, testosterone given prenatally 
actually enhanced feminine and masculine behaviour in 
males suggesting a role for prenatal androgens in 
masculinization but not defeminization of the CNS. 
Antiandrogens given prenatally have been reported to impair 
male sexual behaviour in adult hamsters (Swanson, 1971).
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Perinatal exposure to testosterone in conjunction with 
morphine resulted in all three groups of females displaying 
masculine sexual behaviour. There was also an increase in 
the numbers of females mounting in each group. This is 
contrary to previous reports on masculinization of the 
female hamster, where prenatal androgens were unable to 
cause masculinization (Nucci & Beach, 1971). The role of 
the opiate must also be considered when discussing the 
present findings, and it is possible that alterations to 
neural systems as a result of opiate exposure have allowed 
them to become more sensitive to androgens or to remain 
sensitive over a longer time period. Exposure to exogenous 
opiates during the neonatal period has been shown to down- 
regulate opioid receptors in the CNS (Tempel et al. 1988).
Opioid receptor concentrations change in response to 
exogenous androgens (Hammer, 1985; Martini et al. 1989) and 
endogenous opioids are known to be involved in the control 
of adult sexual behaviour in the rodent (Meyerson, 1981; 
Sirinathsinghj i et al, 1983). Thus by altering the
receptor concentrations during development, opioid control 
of behaviour may also be changed resulting in a higher 
sensitivity to exogenous androgens in adulthood as has been 
shown in females in this investigation.
While it has been demonstrated that testosterone given 
concurrently with morphine pre + postnatally and 
postnatally has reversed the effects of morphine on the 
defeminization process in male hamsters, the additional 
effects of prenatal morphine + T enhancing both feminine
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and masculine sexual behaviour remain to be explained. 
The results suggest that morphine exposure during this 
period might be acting on other systems as well as or 
instead of endogenous androgen production.
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E xper im ent  2:
Does Tes tos te rone  counteract  the effects of morphine?
Females
Behaviour lordosis
latency
to ta l
lo rdos is
maximum
lordos is
%
showing
lordosis
t r e a tm e n t n
prena ta l
morphine
19 145+48 
* *
365+46 264+44 89%
prena ta l  
morphine + 
t e s to s t e r o n e
6 112+ 98 350+88 168+51 83%
pre + post 
morphine
18 13+3 498+15 256+27 100%
pre+post  
morphine + 
t e s to s t e r o n e
16 98+50 420+45 192+58
*
87%
p o s tn a ta l
morphine
28 73+26 445+35 298+38 96%
p o s tn a ta l  
morphine + 
t e s to s t e r o n e
10 238+84
** 0 0 0 0
194+66
** 0 0 0 0
82+33
** 0 0 0 0
70%
contro l 15 25+4 431+44 322+60 100%
F value 2.14
p<0.04
2.97
p<0.01
2.52:
p<0.02
Table 2:9. Feminine sexual behaviour as displayed by adult female 
hamsters treated perinatally with morphine or morphine and 
t e s to s te ro n e .
Scores in seconds. Group mean + SEM.
* differs from controls p<0.05 
** differs from controls p<0.01 
0 0 0 0  differs from morphine only, over the same period p<0.01
Experiment  2:
Does Tes tos te rone  coun te rac t  the effects of m orphine?
Males
Behaviour lordosis
la tency
to ta l
lordosis
max.
lordosis
%
showing
lordosis
t r e a t m e n t n
p ren a ta l
morphine
18 360+61 76+27 26+9 50%
prena ta l  
morphine + 
t e s to s t e r o n e
14 188+60 172+42
0 0  *
64+17
** 0 0 0 0
86%
pre & post 
morphine
26 123+33
* *
165+25 
* *
47+8 92%
pre & post 
morphine + 
t e s t o s t e r o n e
15 424+60
0 0  0 0
36+18
0 0  0 0
11+4
0 0  0 0
35%
p o s tn a ta l
morphine
25 187+43
**
126+22
*
42+7 88%
p o s tn a ta l  
morphine + 
t e s t o s t e r o n e
17 469+52
0 0 0 0
39+16
0 0
16+7
0 0
35%
contro l 19 360+60 76+23 28+8 53%
F value 7.15
p<0.01
4.81
p<0.01
3.70
p<0.01
Table 2:10. Feminine sexual behaviour as displayed by adult 
male hamsters treated perinatally with morphine or morphine 
and testosterone.
Scores in seconds. Group mean + SEM.
* differs from controls p<0.05 
** differs from controls p<0.01 
0 0  differs from morphine only over the same period p<0.05 
0 0 0 0  differs from morphine only over the same period p<0.01
E x p e r i m e n t  2:
D o e s  Te s t o s t e r o n e  c o u n t e r a c t  t h e  e f f e c t s  of m o r p h i n e ?
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Fig 2:13 Fem ales
lordosis
latency
total
lordosis
maximum
lordosis
n _
19 ■  prenatal mor 
6 5  prenatal m+T 
i s D  pre&pos mor 
1 6 0  pre&pos m+T 
28 ■  postnatal mor 
1 0 0  post.mor+T 
15 □  control
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Fig 2:14 Males
lordosis
latency
to ta l
lo rdosis
maximum
lordosis
. * 
*  * * d i f f e r s  f r o m  c o n t r o l s  p < 0 . 0 5 :  p < 0 . 0 1
n _
18 ■  prenatal mor.
14 H  pre mor+T 
26 E3 pre&pos mor
15 E2 pre&pos m+T 
25 H  postnatal mor 
1 7 ^  post mor+T
19 □  control
< d i f f e r s  f r o m  m o r p h i n e  o n l y  o v e r  s a m e  p e r i o d  p < 0 . 0 5 :  p < 0 . 0 1
Experiment  2:
Does T es tos te rone  counterac t  the effects of morphine .?
Fem ales
Behaviour mount
latency
to ta l
mounts
to ta l
grooms
to ta l
in trom
%
mounting
t r e a t m e n t n
p ren a ta l
morphine
1 9 592 + 6 0 0 0 11%
p ren a ta l
morphine*
t e s t o s
6 408+41
>K>1* 0 0 0 0
12+4
** 0 0 0 0
10+3
** 0 0 0 0
4+2
♦ 0 0
83%
pre&post
morphine
1 8 597+2 0 0 0 11%
pre&post
morphine
+ te s to s
1 8 478+34
** 0 0 0 0
7+3
** 0 0 0 0
5+2
** 0 0 0 0
3+2
* 0 0
61%
p o s tn a ta l
morphine
27 586 + 7 0 0 0 15%
p o s tn a ta l
morphine*
t e s t o s
9 360+48
** 0 0 0 0
16+4
** 0 000
6+2 
** 0 0 0 0
1±1 100%
con tro l 12 574+12 1 1 0 50%
F value 18.5
p<0.01
12.4
p<0.01
8.98
p<0.01
4.02
p<0.01
Table 2:11. Masculine sexual behaviour as displayed by adult 
female  hamsters treated perinatally with morphine or 
morphine and testosterone.
Latency = average score over three tests (seconds).
Other scores are the total for the three test periods. 
Group means + SEM.
* differs from morphine only over same period p<0.05 
** differs from morphine only over same period p<0.01 
0 0  differs from controls p<0.05 
0 0 0 0  differs from controls p<0.01
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E x p e r i m e n t  2:
Does T es to s te ro n e  coun te rac t  the  effects of m orph ine?
Males
Behaviour mount
la tency
to ta l
mounts
to ta l
grooms
t o ta l
in t ro m i t
%
mounting
t r e a t m e n t n
p re n a ta l
morphine
1 8 352+32 26+5 23+5
*
16+4
* *
100%
p ren a ta l
morphine+
t e s t o s
1 1 249+45
0 0  *
51+7
0 0  0 0  
* *
48+7
0 0  00 
* *
35+6
0 0  0 0  
* *
100%
pre&post
morphine
25 434+18 14+3 10+2 3+1 92%
pre&post
morphine+
t e s t o s t
1 5 4 04+40 26+5 24+5
*
18+5 
* *
80%
p o s tn a ta l
morphine
25 381+29 22+4 17+3 9+3
*
92%
p o s tn a ta l
morphine+
t e s t o s
1 7 358+31 28+5
*
24+4
*
12+3 
* *
88%
contro l 1 7 377+26 14+2 10+2 2+1 100%
F value 3.01:
p<0.01
6.67:
p<0.01
8.60:
p<0.01
10.51:
p<0.01
Table 2:12. Masculine sexual behaviour as displayed by adult 
male hamsters treated perinatally with morphine or morphine 
and testosterone.
Latency = average score over three test periods.in secs 
Other scores are totals for the three test periods.
Group means + SEM
* differs from controls p<0.05 
** differs from controls p<0.01
0 0  differs from morphine only over the same period p<0.05 
0 0 0 0  differs from morphine only over the same period. p<0.01
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Experiment 3
Does Naltrexone counteract the effects of morphine?
From Expt. 2 it has been shown that testosterone 
counteracts most of the effects of perinatal morphine 
exposure. However there are some unexpected alterations to 
behaviour as a result of concurrent testosterone 
administration which are difficult to explain, particularly 
in males treated prenatally. To try and be more precise in 
determining the action of morphine a third experiment was 
set up in which the long-acting opiate antagonist 
naltrexone (NTX) was administered concurrently with
morphine. Since the earlier findings indicated that 
prenatal morphine alone had little effect on masculine or 
feminine sexual behaviour in males or females, this 
treatment period was omitted from this experiment. An
additional group treated postnatally with NTX only was 
however added. Therefore the following groups were set up:-
Pre + Postnatal
1. lOmg/kg Duromorph ip twice daily + 50mg/kg NTX sc
once daily was given to pregnant hamsters from day 13 of 
pregnancy until parturition and to the pups from the day 
of birth for 4 days (n=9 females, 13 males).
Postnatal
2. lOmg/kg Duromorph ip twice daily + 50mg/kg NTX sc
once daily was given to pups from the day of birth for 
four days (n=21 females, 15 males).
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3. 50mg/kg NTX sc once daily was given to pups from the 
day of birth for 4 days (n=14 females, 11 males).
All other conditions and treatments were as in Expt 1.
Results 
Feminine behaviour
Females (See Table 2:13 Fig. 2:17)
Females treated pre + postnatally with morphine + NTX 
showed a significant decrease in the amount of feminine 
sexual behaviour displayed. Lordosis latency was 
increased, while total and maximum periods of lordosis were 
decreased. No other treatment group in this experiment 
differed significantly from the controls in their ability 
to display lordosis.
Males (See Table 2:14 Fig 2:18)
NTX given with morphine reversed the effects of opiates on 
the ability to display feminine sexual behaviour in males. 
Postnatal NTX given alone had no effect on feminine sexual 
behaviour in males.
Masculine sexual behaviour
Females (See Table 2:15, Fig 2:19)
Neither NTX injected alone or with morphine had any effect 
on masculine sexual behaviour in females; no group in this 
experiment showed any significant mounting behaviour.
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Males (See Table 2:16, Fig 2:20)
NTX alone given postnatally resulted. in a marked 
enhancement of mounting behaviour in males; in particular 
it caused a significant reduction in mount latency while 
increasing all other aspects of masculine sexual behaviour. 
NTX given concurrently with morphine postnatally also 
enhanced the number of mounts and intromissions but did not 
affect the mount latency.
Discussion
The results from this experiment indicate that the 
changes noted in feminine sexual behaviour in the male 
golden hamster exposed to opiates during the perinatal 
period are opiate mediated. Evidence for this is:- 
NTX given concurrently with morphine reverses the opiate 
effect on defeminization, such that males treated with both 
morphine and NTX do not differ from controls in the amount 
of feminine sexual behaviour displayed. NTX alone 
postnatally had no effect on the males' ability to display 
lordosis. These results suggest that the endogenous 
opioids do not participate in the defeminization process in 
the males of this species. In contrast, when masculine 
behaviour in males is considered, although morphine alone 
appeared to have little effect on mounting it did increase 
the number of intromissions in each test. However the 
administration of NTX concurrently with morphine, or on its 
own postnally significantly enhanced both the number of
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mounts and intromissions. NTX alone postnatally also 
markedly reduced the mount latency in males. This would 
suggest that the endogenous opioids might be actively 
involved in the patterning of adult masculine behaviour 
during the postnatal period in the Golden hamster. It is 
possible that the increased masculine behaviour in these 
males is due to increased testosterone production from the 
testes during the postnatal period. Anandalaxmi & Vijayan 
(1989) reported increased plasma gonadotrophin and 
testosterone levels in rat pups given naloxone fron day 1- 
21 postnatally. The fact that there was a marked increase 
in masculine sexual behaviour in males treated with 
testosterone concurrently with morphine adds support to 
this theory.
General Discussion.
In female hamsters, morphine exposure during the 
perinatal period had little effect on their ability to 
display normal feminine sexual behaviour except to increase 
lordosis latency in the group treated prenatally and thus 
slightly decrease the total amount of lordosis. None of 
the treatments had any effect on the females' inability to 
show mounting. That latency to lordosis has been altered 
suggests that these females have been affected such that 
their ability to respond to the advances of a stud male has 
been reduced; once lordosis was initiated, there was no 
difference between the treated animals and the controls. 
Vathy et al, (1983) reported that prenatal morphine
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sulphate administiration partially inhibited feminine 
behaviour in female rats. Since prenatal androgen 
administration concurrently with morphine did not alter the 
females ability to show lordosis this would suggest that 
the changes noted in this group were not mediated via 
androgen responsive mechanisms. Surprisingly, females 
treated pre and postnatally with morphine showed no change 
whatsoever in their adult sexual behaviour, either feminine 
or masculine. One might have expected, since prenatal 
morphine exposure had affected the females response to male 
advances, that a continuation of the opiate treatment into 
the postnatal period would have had a more marked effect. 
Nor is the change in response likely to be as a result of 
stress due to handling, as has been reported in the rat 
(Herrenkohl, 1983) since both prenatally and pre + 
postnatally groups were handled equally prior to 
parturition and only the prenatally-treated females have 
shown any changes in behaviour.
Androgen administration concurrently with morphine 
prenatally and pre + postnatally did not significantly 
reduce feminine sexual behaviour in females except that the 
maximum single episode of lordosis in females treated pre + 
postnatally was reduced when compared with controls. In 
contrast, androgen + morphine postnatally markedly reduced 
the quantity of lordosis in females. Since postnatal 
morphine alone had no effect on lordosis, it must be 
assumed that the changes observed in this group were 
caused by the steroid administration. This is in
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agreement with previous findings in hamsters (Debold & 
Whalen, 1975; Whalen & Etgen, 1978), mice (Manning & 
McGill, 1974) and rats (Whalen & Edwards, 1967).
Perinatal androgen + morphine had a more marked effect 
on the female hamsters1 ability to display mounting 
behaviour. Females in all three treatment groups mounted 
and displayed intromission-like behaviour. This is 
surprising since investigations to determine the critical 
period for masculinization of the golden hamster have 
suggested that androgen administration prenatally would 
have little significant effect on masculinization of 
behaviour in the female of this species (Nucci & Beach, 
1971). Therefore, the present findings would suggest that 
the opiates have had an effect in facilitating 
masculinization of females prenatally exposed to androgens. 
Perhaps this has been mediated by alterations to the neural 
substrate involved in establishing masculine behaviour. It 
has been shown that perinatal morphine exposure alters the 
developmental patterns of the endogenous opioid systems (Di 
Guilio et al, 1988) and that the endogenous opioids are
involved in control of sexual behaviour (Murphy, 1981).
When the opiate antagonist NTX is given alone or in 
conjunction with morphine postnatally, there is no change 
in either feminine or masculine behaviour in females. 
However extending the treatment into the prenatal period 
results in a marked reduction of feminine sexual behaviour. 
How these changes are mediated is unclear since morphine
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alone had no significant effect during either of these 
treatment periods nor did NTX alone postnatally have any 
significant effect.
NTX alone given postnatally is reported to enhance 
lordosis behaviour in female rats (Meyerson et al. 1988).
Morphine binds to both fi and 6 receptors in the brain, but 
binds preferentially to /x receptors. Prenatal exposure to 
morphine has been shown to down-regulate opiate receptors 
in the neonatal rat brain (Tempel et al. 1988) while
naloxone (a morphine antagonist) increases /x-receptor 
numbers (Bardo et al. 1982). Naloxone binds to all three
opioid receptor-types, thus it is possible that the 
changes noted in this investigation were mediated via the k 
receptors. To test this, a specific k receptor ligand such 
as dynorphin should be employed with morphine and 
naltrexone. If the changes observed are mediated via k 
receptors, blocking of these receptor with a specific 
ligand may reverse the effects.
In contrast, morphine exposure during the perinatal 
period has a marked effect on the adult sexual behaviour of 
male hamsters which is completely reversed by NTX. Males 
administered morphine over the pre and postnatal period or 
just postnatally, showed a significant increase in feminine 
sexual behaviour. Prenatal morphine, on the other hand, 
did not facilitate the expression of lordosis in male 
hamsters. Defeminization takes place during the early 
postnatal period in the golden hamster (Carter et al, 1972, 
Payne, 1976). Testosterone administered concurrently with
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morphine reversed the effects of morphine alone in the pre 
+ postnatal and postnatally treated males. However, 
testosterone given in addition to morphine prenatally had 
the reverse effect in that these males displayed 
significantly more feminine sexual behaviour than did 
controls. How this action is mediated is unclear. However 
one could speculate that a high dose of steroid prenatally 
may desensitise the CNS such that it is unable to respond 
to endogenous androgens present during the early postnatal 
period and so undergo the normal process of defeminization. 
Thus this action may have been mediated via a down- 
regulation of androgen receptors in the areas of the CNS 
involved in sexual differentiation. However when the
masculine sexual behaviour of the same group of animals is 
considered it will be noted that prenatal morphine + 
testosterone markedly enhanced masculine sexual behaviour. 
Prenatal morphine alone also increased the number of 
intromissions in this group. Thus it would seem that males 
exposed to both opiates and steroids prenatally have become 
bisexual, they will readily respond to a receptive female 
with mounting behaviour, but are equally capable of 
adopting the lordotic posture after the appropriate priming 
when approached by other males. It must be pointed out 
that, while these males showed increased feminine sexual 
behaviour, no group spent as much time in lordosis as 
normal females. Since masculine sexual behaviour was 
increased after this treatment it seems unlikely that the
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effects were mediated via a down-regulation of androgen 
receptor numbers. If the action is by receptor reductions, 
it would imply that while the neural substrate mediating 
defeminization has become less sensitive to androgen 
postnatally, the substrate mediating masculinization has 
become more sensitive. From Appendix 1:3 it can be seen 
that morphine administered prenatally accumulates in 
relatively high concentrations in the fetal brain. Acute 
prenatal opiate administration has been reported to have 
many effects on the developing CNS, including alterations 
in postnatal neurotransmitter levels (Rech et al , 1980)
and synaptogenesis (Seidler et al. 1987). In culture,
opiates inhibit serotonin uptake (Davila-Garcia & Azmitia, 
1989) and in vivo reduce androgen production (Singh et al. 
1980; Anandalaxmi & Vijayan, 1989). The multiple effects 
of opiates on the developing organism makes it very 
difficult to determine by which methods the drug has caused 
the changes in behaviour reported here.
When masculine behaviour in treated males is examined 
it can be seen that all treatments, except continuous 
opiate treatment pre + postnatally, significantly increased 
intromission scores. This is normally a particularly 
androgen-sensitive behaviour (only females treated 
neonatally with androgens displayed any intromission-like 
behaviour). However, it would seem that the changes in 
behaviour were not as a result of reduction in endogenous 
androgens, since radioimmunoassay of circulating plasma 
androgens in 2 day old male hamsters treated with opiates
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shows no reduction (see appendix 2)
During late gestation and in the early postnatal 
period a considerable amount of neuronal growth, cell death 
and synaptogenesis is occuring in the mammalian neonate. 
It has been shown both in vivo and in vitro that opiates 
can interfere with these processes, and indeed that the 
endogenous opioid peptides are involved in the regulation 
of some of them. The hypothalamus, which is deeply 
involved in control of reproductive behaviour, has a high 
concentration of opiate receptors ( Simon & Hiller, 1978) 
and of opioid neural pathways (Simerly et al.1988). Thus, 
it is not surprising that changes in reproductive behaviour 
would become apparent, as in this investigation, when acute 
opiate administration is applied to the developing animal 
during the perinatal period.
In this investigation postnatal NTX markedly enhanced 
mounting behaviour in male hamsters. This is in contrast to 
findings in the rat (Meyerson et al, 1988) where 10^g
NTX s.c. on days 1-10 postnatally had no effect on 
masculine behaviour in males. However, the dose used in 
this experiment was higher, 250/xg s.c. on days 1-4 
postnatally, and may have had a more pronounced effect. 
It is possible that the enhanced masculine behaviour may 
have been caused by an increase in endogenous testosterone 
under NTX stimulation. It is unlikely though that 
endogenous production would match the levels of the 
exogenous androgen administered in expt 2 which did enhance
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male behaviour, but not to the same extent as did NTX. in 
fact, the levels of masculine behaviour in the NTX-treated 
males are comparable to those treated prenatally with 
morphine and testosterone. Here are two dissimilar 
treatment regimes, given over different periods, yet 
having a similar effect on mounting behaviour. However 
here the comparison ends as, prenatal morphine + 
testosterone also enhanced feminine sexual behaviour in 
males while NTX postnatally did not. Thus while the end 
results are similar, it is most unlikely that they were 
reached in the same manner.
The long-acting opiate antagonist, NTX blocks opiate 
receptors thus preventing the endogenous opioids from 
influencing neural development. It is believed that the 
endogenous opioids have an inhibitory influence on neural 
growth and development, mainly in regulating dendritic 
outgrowth and synaptogenesis. Opioid antagonists enhance 
dendritic arborisation in the developing rat (Zagon & 
McLaughlin, 1984, 1986; Hauser et al, 1987 ). Therefore it 
is feasible that NTX - treated animals may have developed 
neuronal networks specifically involved in male sexual 
behaviour which are exquisitely sensitive to androgens in 
adulthood. When such animals are primed with androgen and 
encounter a receptive female, they respond faster (as is 
noted in the reduced mount latency) and with more vigour
than do normal males.
In conclusion, acute morphine exposure over the 
perinatal period has little effect on the female golden
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hamsters' ability to show normal sexual behaviour patterns
but has a profound effect on the male. Males so - treated
show pronounced bisexual behaviour, in that they respond to 
encounters with stud males by adopting the lordotic stance, 
while they are equally responsive when placed with an 
oestrous female and will readily mount and intromit.
In the second part of experiment 1, animals which had 
been exposed to morphine throughout gestation and into the 
postnatal period, were tested for sexual behaviour. As 
with the acutely -treated females, those treated 
chronically with morphine showed no significant difference 
in either feminine or masculine sexual behaviour. However,
the males again showed altered adult behaviour. Lordosis
latency was reduced and total lordosis increased [although 
not quite significantly] indicating that chronic morphine 
treatment has altered the males' responsiveness to stud 
males. However a surprising aspect of this part of the 
investigation was that masculine sexual behaviour was also 
significantly increased. This finding suggests that long­
term exposure to opiates is less harmful than is short­
term, and is consistent with proposals by Lichtblau & 
Sparber (1983). These authors reviewed several studies on 
prenatal opiate exposure and concluded that many of the 
detrimental changes reported (e.g. low birth weight and 
early postnatal death) may have been caused by the fact 
that the drug was given acutely and that the animals had 
not had time to build up tolerance to it.
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Experiment  3:
Does Nal trexone  counterac t  the effects of morphine?
Fem ales
Behaviour lordosi s 
latency
to ta l
lo rdosis
maximum
lordosis
% showing 
lo rdosis
t r e a tm e n t n
p o s tn a ta l
na ltrex one
12 125+46 409+45 237+46 92%
pre& post
m orphine
18 13+3 498+15 256+27 100%
pre& post
morphine+
na ltrex one
9 226+94
** 0 0 0 0
281+85
* 0 0
143+58
*
67%
p o s tn a ta l
m orphine
28 73+26 445+35 298+38 96%
p o s tn a ta l
morphine+
na ltrexo ne
21 111+43 362+45 218+40 90%
con tro l 15 25+4 431+44 322+60 100%
F value 3.16
p<0.01
2.42
p<0.04
1.57
n.s.
Table 2:13 Feminine sexual behaviour as displayed by adult 
female hamsters treated perinatally with morphine or 
morphine and naltrexone.
Scores in seconds. Group mean + SEM
* differs from controls p<0.05 
** differs from controls p<0.01
0 0  differs from morphine only over same period p<0.05
0 0 0 0  differs from morphine only over same period p<0.01
Exper im en t  3
Does Nal trexone counteract  the effects of morphine?
Males
Behaviour lordosis
latency
to ta l
lo rdosis
maximum
lordos is
% showing 
lordosis
t r e a tm e n t n
pre& post
m orphine
26 123+33 
* *
165+25
*
47+8 92%
pre& post
morphine*
na ltrexone
13 394+75
0 0  0 0
83+33
0 0
22+10
0 0
38%
p o s tn a ta l
m orphine
25 187+43 
* *
126+22
*
42+7 88%
p o s tn a ta l
morphine*
na ltrexone
15 445+61
0 0  0 0
72+32 33+14 40%
con tro l 19 360+60 76+23 28+8 53%
p o s tn a ta l
na ltrexone
7 378+95 95+61 36+22 43%
F value 6.33
p<0.01
2.10
n.s.
0.92
n.s.
Table 2:14 Feminine sexual behaviour as displayed by adult 
male hamsters treated perinatally with morphine or morphine 
and naltrexone.
Mean scores in seconds + SEM.
* differs from controls p<0.05
** differs from controls p<0.01
0 0  differs from morphine only over same period p<0.05
0 0 0 0  differs from morphine only over the same period p<0.01
E x p e r im e n t  3:
Does Nalt r e xone  c o u n te r a c t  the e f fec ts  of morphine?
CO■o
coo0)
CO
500 -
400 -
300 -
200 -
100 -
1 8 □  pre&pos mor 
9 H  pre&pos m+nx 
28 0  postnatal mor 
21 0  post mor+nx 
1 2 □  post nx 
1 5 0  control
Fia. 2:17 Fem ales lordosis
la tency
total
lordosis
maximum
lordosis
COTJ
Coo©
co
500 -
400 -
300 -
200 -
100 -
Fig. 2:18 Males
lordosis
la tency
to tal
lordosis
maximum
lordosis
26  □  pre&pos mor 
1 3 H  pre&pos m+nx 
25 B postnatal mor 
1 5 E2 post mor+nx 
7 □  post nx 
19 0  control
* : * # d i f f e r s  f r o m  c o n t r o l s  p < 0 . 0 5 :  p < 0 . 0 1
< : « d i f f e r s  f r o m  m o r p h i n e  o n l y  o v e r  s a m e  p e r i o d  p < 0 . 0 5 :  p < 0 . 0 1
E xper im ent  3:
Does Nal t rexone  c o u n te rac t  the effects of morphine?
Fem ales
Behaviour m ount
la tency
to ta l
m ounts
to ta l
grooms
to ta l
in trom
%
showing
mounting
t r e a tm e n t n
pre& post
m orphine
1 8 597+2 0 0 0 11%
pre& post
morphine+
NIX
9 596+3 0 0 0 22%
p o s tn a ta l
m orphine
27 586+7 0 0 0 15%
p o s tn a ta l
morphine+
NIX
2 1 565+17 2+1 3+2 0 5%
con tro l 1 2 574+12 1 1 0 50%
p o s tn a ta l
NIX
1 4 567+29 3+2 3+2 3+2 21%
F value 1.36
n.s.
1.79
n.s.
1.81
n.s.
0.00
n.s.
Table 2:15. Masculine sexual behaviour as displayed by adult 
females treated perinatally with morphine, or morphine and 
naltrexone, (NTX) or naltrexone alone.
Latency = average over three tests, in seconds 
Other scores are total counts over three test periods.
Group means + SEM.
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E xp er im en t  3:
Does N a l t rexo n e  c o u n te rac t  the  effects of m orph ine?
Males
Behaviour m ount
la ten cy
to ta l
m ounts
to ta l
groom s
to ta l
in trom
%
showing
mounting
t r e a tm e n t n
p o s tn a ta l
n a ltrex o n e
1 1 230+47
’t4 0 0 0 0
53+8
H4 H4 O O O O
50+8
^ H4 O O O O
31+6
^ ^  O O O O
91%
pre& post
m orphine
25 434+18 14+3 10+2 3+1 92%
pre& post
morphine+
n a ltrex o n e
1 3 385+24 23+3 21+3
*  0 0
7+2 100%
p o s tn a ta l
m orphine
25 381+29 22+4 17+3 9+3
*
92%
p o s tn a ta l
morphine+
n a ltrex o n e
15 364+28 34+6
^  ^  O O
31+6
^ H4 O O O O
17+4
** 0 0
100%
co n tro l 17 369+26 15+2 10+2 3+1 100%
F value 4.60:
p<0.01
10.28:
p<0.01
13.18:
p<0.01
12.81:
p<0.01
Table 2:16 Masculine sexual behaviour as displayed by adult 
male hamsters treated perinatally with morphine, or morphine 
and naltrexone, or naltrexone.
Latency = average over three tests in seconds 
Other scores are totals over three test periods.
Group means + SEM.
* differs from controls p<0.05 
** differs from controls p<0.01
0 0  differs from morphine only over same period p<0.05
0 0 0 0  differs from morphine only over same period p<0.01
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Appendix 2
Research into the sexual differentiation of adult 
sexual behaviour in the rodent has shown that castration 
within 24 hours of birth results in males which display 
significantly more feminine sexual behaviour as adults 
after appropriate priming, than do intact males or males 
castrated in adulthood.
Androgens acting postnatally have been shown to be 
important in the sexual differentiation of gonadotropin 
release patterns, morphology of dimorphic structures in the 
CNS and differences in hypothalamic monoamine levels during 
the critical period.
In the adult rat, opiate administration causes a 
reduction in gonadotropin release from the anterior 
pituitary resulting in a decline incirculating androgens. 
Similar results have been reported in neonatal rats. Thus 
it was important to determine whether opiate 
administration, as used in this investigation, lowers 
circulating testosterone levels in the neonatal male 
hamster. Two groups of animals were established:-
1) saline-treated male pups (controls)
2) morphine-treated male pups 
Procedure
Treatment: Male pups were given lOmg/kg Duromorph i.p. or
saline twice daily on the day of birth (day 1) and on day 
2.
Two to three hours after the final injection, pups were 
sacrificed by cervical dislocation and trunk blood was
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collected in heparinised tubes. Since testosterone levels 
are very low in the neonatal hamster (Pang & Tang, 1983) 
blood from 18-2 0 pups was pooled for each sample. Control 
pups were treated with saline.
The blood samples were centrifuged at 3200 rpm for 3 
minutes and the separated plasma stored at -20°C until 
assayed.
The testosterone radioimmunoassay was carried out in 
the Department of Pathological Biochemistry at the Royal 
Infirmary, Glasgow by Mr Stuart Keir.
Testosterone levels were measured by using a 125I- 
tracer and double antibody separation. Data were analysed 
using Student's unpaired t-test.
Results
Control n = 4: testosterone levels = 0.445 ± 0.09 nM/1 
Morphine-treated n = 4: testosterone levels = 1.21 ±
0.52 nM/1
DF = 6: t =1.44: p < 0.2; not significant.
These results indicate that morphine-treatment 
postnatally has had no effect on the levels of circulating 
androgens in the male hamster. Plasma from pre-natally 
treated animals was not analysed at this stage. Further 
studies are required to determine whether prenatal exposure 
to opiates would lower plasma androgens. In-vitro studies 
of testosterone output from hamster testes from E14 and E15 
fetuses and postnatal days 1 and 2 have shown that androgen 
output is higher prenatally and more responsive to hCG than
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testes from day 1 or 2 pups (Vomachka & DiMario, 1987) . 
Masculinization of behaviour is believed to occur in the 
postnatal period in the hamster since prenatal androgen 
does not masculinization female hamsters (Nucci & Beach, 
1971) .
In addition, preliminary studies of androgen levels in 
postnatally morphine-treated rats did not reveal any 
change; Control levels = 2.78nM/l 
Morphine treated pups = 3.4nM/l.
However, only two pooled samples were used in this study 
and sample numbers need to be increased before any 
conclusions can be drawn.
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Chapter 3 
The effects of perinatal opiate administration on the 
concentrations of hypothalalmic neurotransmitters at 
postnatal day 4 or 12 ■
The monoaminergic neurotransmitter systems are amongst 
the earliest to develop in the mammalian brain. This 
early ontogeny suggests that these systems may be active 
in regulation of brain development . Indeed, serotonin 
(5HT) has been reported to act as a signal for neural 
differentiation in vitro and in vivo (Lauder and Krebs, 
1978; Lauder et al. 1982).
Dopaminergic (DA), noradrenergic (NA) and serotonergic 
(5HT) neurones are located in various regions of the CNS; 
all three monoamines occur within the hypothalamus and are 
known to be involved in the control of sexual behaviour 
(Agmo & Fernandez, 1989; Vathy & Etgen, 1989) and 
gonadotrophin release (Negro-Vilar et al, 1984; Clayton,
1988) .
Serotonin in particular is reported to show a 
transitory sexual difference in levels in the rat (Ladosky
& Gaziri, 1970) and hamster (Johnston et ad, 1990)
hypothalamus, being higher in females than in males at 12 
days after birth. This difference in serotonin 
concentration is dependent on postnatal androgen levels, 
as castration before day 5 increases concentrations in 
males to that found in females (Ladosky & Gaziri, 1970).
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Conversely androgen administration to female pups 
postnatally, reduces levels to that of males (Giulian et 
al, 1973).
Neonatal reduction of 5HT levels by treatment with 
pCPA results in both behavioural (Hyyppa et al. 1972;
Wilson et al, 1986), and morphological changes in the rat 
CNS (Handa et al, 1986), although the latter is reported
to be temporary (Hines & Gorski, 1986). Nonetheless, 
these alterations may be important during the development 
and differation of the CNS. Since the monoamines are 
believed to have trophic effects during 
morphogenesis (McMahon, 1974; Lanier et al. 1976) it is
important to consider the possible effects that 
alterations to these levels might have on sexual 
differentiation.
In the previous set of experiments it was shown that 
opiate administration during the perinatal period altered 
the ability to display feminine sexual behaviour. These 
behavioural changes may have been mediated via decreased 
synaptogenesis, or neural migration, since opiates can 
inhibit these processes. On the other hand they possibly 
may have resulted from alterations in monoamine levels 
during this critical period of sexual differentiation. 
There is no compelling evidence that they relate to 
reduced androgen levels (see appendix 2) even though they 
are reversed by testosterone administration, as well as by 
naltrexone.
While changes in behaviour can be effected m
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E l e c t r o c h e m i c a l
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Potent iostat
C h r o ma to g ram
Fig.3:1. Schematic diagram of HPLC apparatus.
t
i
adulthood by manipulating monoamine concentrations and 
turnover, it would be unwise to assume that similar 
changes in the perinatal period would have the same 
effect. However, behavioural patterns are being 
established during the perinatal period and it has been 
shown that 5HT manipulation during this time does affect 
behaviour in adults. Thus, if opiates affect the 
concentrations of the amines during this period, it could 
be speculated that these changes have contributed to the 
behavioural alterations.
In the present experiment amines were measured by 
excising the hypothalamic tissue, homogenising it and 
after centrifugation injecting the supernate into a 
chromatographic column in which the components of the 
mixture were separated and finally measured. A brief 
description of the system used follows .(Also see Fig. 
3:1)
Separation of components bv HPLC.
The apparatus used for the analysis of biogenic amines 
in this experiment was a High Performance Liquid 
Chromatography (HPLC) system coupled to an electrochemical 
detector.
HPLC is a method of separating different components of 
a mixture by a successive series of equilibrium stages. 
These equilibria depend on the differential adsorption of 
the components between two phases; a mobile phase, the
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eluant, and a stationary phase. The sample mix is 
introduced into the mobile phase and carried through the 
chromatographic column, undergoing a series of partition 
or adsorption interactions between two phases as it goes. 
The components of the sample mixture pass through the 
column at different rates according to their physical and 
chemical properties, such that those with the greatest 
affinity for the stationary phase will take longest to 
move through the system.
The eluent is continually monitored by the detector 
system. As each component leaves the column, it passes 
over the electrode and is oxidised; the resulting current 
generated in the flow cell is displayed as a peak on the 
integrator. Ideally, each component should be eluted such 
that the peaks do not overlap, and should show maximum 
height and minimum width. Thereby resulting in good 
resolution, efficiency and selectivity. The time between 
injection of the sample and the elution of each component 
in the mixture is referred to as the retention time and is 
dependent on the molecular interactions between the two 
phases. It is also subject to changes in the environment 
such as temperature, pH and solvent concentration. To 
allow for these changes, and to determine the identity of 
each peak as it is eluted, a standard mixture of the 
components of interest is analysed at the start of each 
day and at various times throughout the day as the 
retention times change.
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Electrochemical Detection:
As an electrically active molecule passes through the 
flow cell it is oxidised, and the current generated is 
displayed as a peak on the integrator. The detector cell 
consists of 3 electrodes, a working electrode (in this 
case glossy carbon), a reference electrode (Ag/AgCl) and a 
stainless steel auxilliary electrode. The eluant from the 
column enters a very low volume thin-layer cell, where the 
flow is reduced to a thin film passing over a planar 
electrode held at a fixed potential. If the potential is 
greater than that required for the electrolysis of the 
analyte, then a measurable charge passes between the 
electrode and analyte. The resulting current is directly 
proportional to the concentration of solute passing 
through the cell.
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Analysis of hypothalamic samples;
Fig 3:2 is a typical trace recorded when a mixture of 
standards is injected onto the column. As can be seen 
from this trace, there are eight peaks. However, during 
the course of a day, as the ambient temperature of the 
room and the column rises, the elution times of each amine 
is brought forward and peaks appearing close together on 
the trace begin to overlap. In the present study this 
frequently occurred with the MHPG and DOPAC peaks. 
Because of this overlap it was not always possible to 
determine the areas of the two peaks and in these 
instances the concentration of the amines could not be 
calculated. For this reason, concentrations of MHPG and 
DOPAC were not analysed.
Similarly, although the NA peak was easily identified 
when a standard mixture was run through the system it was 
often engulfed by the solvent front (which in a sample 
trace is much larger than that of the standard) (see Fig 
3:3). NA can be analysed readily when conditions are 
suitable, but this system was set up to analyse both 
catecholamines and indoleamines. The optimal condition for 
analysis of the indoles is not the best for analysis of 
the catecholes. Since the concentrations of 5HT were of 
particular interest, NA could not always be accurately 
measured in these samples. This was unfortunate, as NA is 
known to be involved in the control of gonadatrophin 
release (Ranee et al. 1981; Wise et al, 1981) and sexual
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Fig. 3:2. Trace produced vr.en 20 fil of a mixture of 
standards is injected into zhe HPLC system. Each peak 
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Fig 3:3. Trace produced vr.en a sample of hypothalamic 
tissue is prepared and the supernatant injected into the 
HPLC system. Peak labelled ICPAC is DOPAC + MHPG which 
overlap. The NA peak has beer, overlapped by the solvent 
front.
behaviour in the rodent.
Materials and Methods 
High Performance Liquid Chromatography analysis of 
hypothalamic biogenic amines in postnatal hamster puds.
Two separate experiments were performed to detect:
1 Delayed effects of opiates; here the pups were culled 
at 12 days postnatally while the morphine 
administration terminated on day 4.
2 Short-term effects of opiates here pups were culled at 
4 days postnatally (i.e. on the final day of morphine 
administration).
Experiment 1 
Treatments:
All perinatal drug treatments in this experiment were 
the same as those described in the behavioural experiments
(see chapter 2). Groups were as follows
1) Duromorph given prenatally (n=8 females, 6 males)
2) Duromorph pre- and postnatally (n=4 females, 9 males)
3) Duromorph postnatally (n=7 females, 7 males)
4) Duromorph + testosterone prenatally (n=4 females, 
6 males)
5) Duromorph + testosterone pre- and postnatally (n=7 
females, 7 males)
6) Duromorph + testosterone postnatally (n=6 females, 5 
males)
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7) Duromorph + NTX pre- and postnatally (n=5 females,
6 males)
8) Duromorph + NTX postnatally (n=7 females, 6 males)
9) NTX postnatally (n=7 females, 5 males)
10) Saline treated controls (n=7 females, 7 males)
Tissue preparation.
The brain was extracted and the hypothalamus was 
removed by making sagittal cuts on either side of the 
median eminence followed by coronal cuts (1) immediately 
rostral to the optic chiasm and 2) immediately rostral to 
the mammillary bodies (incorporating levels A48-A34 as 
described Knigge & Joseph, 1968). The excised block of 
tissue produced by these cuts was divided horizontally 2- 
3mm above its ventral surface and stored at -80°C until 
processed. Hypothalami were weighed and homogenised in 
600jLtl 0.1M HC1 to which lOOjug/l of internal standard, 
dihydroxybenzylamine (DHBA) had been added. The 
homogenate was centrifuged at 3 000 r.p.m. for 10 minutes 
and the supernatant was injected into the chromatographic 
column in quantities of 2 0/xl; at least 2 injections per 
sample were analysed and any unused supernatant was stored 
at -80°C until further required. The HPLC apparatus 
consisted of a Gilson pump and manometric unit (models 3 02 
and 802 respectively), a Rheodyne 7125 injection valve, a 
15 x 0.4 6cm Ultrasphere ion-pair reversed-phase column 
preceded by a 2 x 0.46cm guard column (both manufactured
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by Beckman), a BioAnalytical Systems flow cell TL-5 and a 
LC-3A electrochemical detector. The potential was set at 
0.70V vs an Ag/AgCl reference electrode ( sensitivity 1 
nA, time constant 5 sec). The output signal was recorded 
and analysed by a Trivector Trio integrator. The mobile 
phase consisted of :-
6.8g/l sodium acetate; 5.75g/l citric acid; 2.4g/l 
sodium hydroxide; 0.037g/l Na EDTA; 0.125g/l heptane
sulphonic acid (Na salt). The pH was adjusted to 4.8 
using glacial acetic acid; the methanol content was 10% 
and the flow rate was 0.6ml/min. (modified from the method 
of Siddiqui & Gilmore, (1986).
Statistics:
All statistical analysis was computer aided. Groups 
were compared using one-way ANOVA followed by inter-group 
comparisons using Least Significant Difference 
Computations. Individual groups were compared where 
necessary using Student's t test.
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Long-term effect of opiates (12 Davs) 
Results
1) Dopamine
Females: (see Table 3:1)
None of the groups treated with morphine showed 
hypothalamic DA levels which differed from those in the 
controls. However females treated postnatally with both 
morphine + testosterone had significantly lower levels of 
DA than did controls or those treated with morphine only. 
In contrast, morphine + testosterone given pre and 
postnatally increased DA levels above those of controls as 
did morphine + naltrexone postnatally.
Males: (see Table 3:2)
Levels of DA were significantly higher in males 
treated pre- and postnatally with morphine or with 
morphine + testosterone when compared to controls. 
Concurrent administration of naltrexone reversed this 
effect. On the other hand, morphine + testosterone 
treatment postnatally significantly reduced DA levels 
below those found in controls or in males treated with 
morphine only postnatally.
2)Homovanillic acid 
Females (see Table 3:3)
None of the perinatal treatments altered hypothalamic
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HVA levels when compared with those of controls. However 
morphine + testosterone administration prenatally 
significantly increased HVA levels beyond those of females 
treated with morphine only over the same period.
Males (see Table 3:4)
There was no significant difference in hypothalamic 
levels of HVA between any of the treatment groups.
3) Serotonin
Females (see Table 3:5)
Morphine administered prenatally significantly reduced 
hypothalamic 5HT levels in females, while concurrent 
testosterone administration reversed this effect. 5HT 
levels in postnatal morphine + testosterone-treated 
females were significantly lower than those in controls or 
those given morphine only postnatally.
Males (see Table 3:6)
Males treated prenatally with morphine + testosterone 
had significantly elevated 5HT levels in comparison to 
controls, or to those treated prenatally with morphine 
only. Males treated with morphine pre- and postnatally 
also had significantly higher 5HT levels than did 
controls, as did males given morphine + naltrexone pre- 
and postnatally.
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4) Hvdroxvindoleacetic acid 
Females (see Table 3:7)
Morphine treatment prenatally and pre + postnatally 
reduced levels of 5HIAA significantly below those of 
controls. In contrast testosterone given in conjunction 
with the opiate over the same period reversed this effect, 
as did naltrexone. Postnatally administered morphine did 
not alter 5HIAA levels in females, but the opiate 
antagonist naltrexone significantly reduced 5HIAA 
concentrations below those of controls and other 
postnatally-treated groups.
Males (see Table 3:8)
None of the perinatal opiate/antagonist treatments had 
any significant effect on hypothalamic 5HIAA levels 
measured in 12-day old male hamsters.
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H ypotha lam ic  do p am ine  levels in neonatal  Golden
H a m s te r  t r ea te d  p e r ina ta l ly  with m o rp h ine  and 
t e s to s te r o n e  or  n a l t r e x o n e .
Females
Treatment DA levels n
prenatal morphine 362 + 33 8
prenatal mor + T 413 + 69 7
pre + post morphine 453 + 46 4
pre + post mor + T 524 + 59 * 7
pre + post mor + NTX 331 + 82 5
postnatal morphine 326 + 27 7
postnatal mor + T 163 + 30 *§ 6
postnatal mor + NTX 517 + 39 *§ 7
postnatal naltrexone 430 + 44 7
control 329 + 56 7
F value 4.46: p<0.01
Table 3:1 Hypothalamic DA levels in 12 day old female 
hamsters . Group means + SEM
M a l e s
Treatment DA levels n
prenatal morphine 366 + 39 6
prenatal mor + T 412 + 67 6
pre + post morphine 564 + 39 * 9
pre + post mor + T 472 + 37 * 7
pre + post mor + NTX 413 + 62 6
postnatal morphine 340 + 44 7
post morphine + T 144 + 36 * § 5
postnatal mor + NTX 372 + 37 6
postnatal naltrexone 434 + 28 5
control 318 ± 35 7
F value 6.15 p<0.01
Table 3:2 Hypothalamic DA levels in 12 day male hamsters 
* differs from controls p<0.05 
§ differs from morphine only over same period.
H y p o th a lam ic  homovani l l ic  acid levels in neonatal  
Golden  H am ste rs  t r e a te d  p e r in a ta l lv  with m orph ine  
and  te s to s te ro n e  or  na l t rexone .
F e m a l e s
Treatment HVA levels n
prenatal morphine 216 + 16 8
prenatal mor + T 337 + 28 § 7
pre + post morphine 434 + 143 4
pre + post mor + T 388 + 78 7
pre + post mor + NTX 419 + 41 5
postnatal morphine 357 + 19 7
postnatal mor + T 272 + 32 6
postnatal mor + NTX 358 + 26 7
postnatal naltrexone 264 + 22 7
control 323 + 32 7
F value F=2.33 p<0.03
Table 3:3 Hypothalamic HVA levels in 12 day female 
h a m s te r s .
Group means + SEM
§ differs from morphine only over same time period: p<0.05
M a l e s
Treatment HVA levels n
prenatal morphine 432 + 101 6
prenatal mor + T 414 + 76 6
pre + post morphine 382 ± 20 9
pre + post mor + T 362 + 44 7
pre + post mor + NTX 285 ± 32 6
postnatal morphine 357 + 35 7
postnatal mor + T 338 + 42 5
postnatal mor + NTX 366 ± 40 6
postnatal naltrexone 304 ± 49 5
control 295 + 16 7
F value 0.98 n.s.
Table 3:4 Hypothalamic HVA levels in 12 day male hamsters. 
Group means + SEM.
H y p o th a la m ic  se ro ton in  levels in neonata l  Golden 
H a m s te r s  t rea te d  p e r in a ta l lv  with m orp h in e  and 
t e s to s t e r o n e  o r  n a l t r e x o n e .
F e m a l e s :
Treatment 5HT levels n
prenatal morphine 803 + 43 ** 8
prenatal mor + T 1251+ 78 §§ 4
pre + post morphine 1194 + 219 4
pre + post mor + T 1303 + 112 7
pre + post mor + NTX 1240 + 56 5
postnatal morphine 1208 + 56 7
postnatal mor + T 892 + 53 * § 6
postnatal mor + NTX 1268 ± 79 7
postnatal naltrexone 1065 + 41 7
control 1156 ± 67 7
F value 4.87: p<0.01
Table 3: 5 Hypothalamic 5HT levels in 2 day
hamsters. Group means + SEM
*: ** differs from controls p<0.05: p<0.01
§: §§ differs from morphine only over same period.
M a l e s :
Treatment 5HT levels n
prenatal morphine 1020 + 58 6
prenatal mor + T 1443 + 175**§ 6
pre + post morphine 1508 ± 94 ** 9
pre + post mor + T 1166 + 68 7
pre + post mor + NTX 1363 + 63 * 6
postnatal morphine 1223 + 87 7
postnatal mor + T 941 + 88 5
postnatal mor + NTX 1253 + 185 6
postnatal naltrexone 1206 + 100 5
control 964 + 29 7
F value 3.65 p<0.01
Table 3:6 ____ _____ _
hamsters. Group means + SEM.
12 day male
H y p o th a la m ic  5 -H vdi  oxv indo leace t ic  acid  levels in
n e o n a ta l  Golden  H a m s te r s  t r e a te d  p e r in a ta l ly  with 
m o r p h in e  and  te s to s te ro n e  or na l t rexo n e .
Fe mal e s
Treatment 5HIAA levels n
prenatal morphine 382 + 13 ** 8
prenatal mor + T 603 ± 48 §§ 7
pre + post morphine 430 + 70 * 4
pre + post mor + T 592 + 41 § 7
pre + post mor + NTX 621 + 52 5
postnatal morphine 601 + 20 7
postnatal mor + T 521 + 56 6
postnatal mor + NTX 650 + 64 7
postnatal nalt rexone 361 + 13**§§ 7
control 582 + 57 7
F value 5.61 p<0.01
Table 3: 7 Hypothalamic 5H1AA levels in 12 day female 
hamsters. Group means + SEM 
* :** differs from controls p<0.05 : p<0.01 
§ §§ differs from morphine only over the same period.
M a l e s
Treatment 5H1AA levels n
prenatal morphine 513 + 58 6
prenatal mor + T 525 ± 98 6
pre + post morphine 608 + 28 9
pre + post mor + T 513 + 53 7
pre + post mor + NTX 593 ± 26 6
postnatal morphine 593 + 49 7
postnatal mor + T 594 + 40 5
postnatal mor + NTX 6 1 1 + 7 7 6
postnatal na lt rexone 459 + 63 5
control 576 + 62 7
F value 0.75 n.s.
Table 3:8 Hypothalamic 5HIAA levels in 12 day male 
hamsters. Group mean + SEM
EXPt 2
Short-term effects of opiates.
Materials and methods
1) Pups treated with lOmg/kg Duromorph ip twice daily from 
the day of birth till culling on Day 4 (n=6 females, 6 
males).
2) Controls which received saline were culled on day 4 
postnatally (n=5 females, 5 males).
Tissue extraction and processing were carried out in a 
similar manner to that described in experiment 1. Since 
the tissue weight from 4 day-old pups was approximately 
50% of that in the 12 day pups, 300jLtl of HC1 were used for 
homogenisation.
Results
Dopamine
Females: (see Table 3:9)
Hypothalamic DA levels were increased in the opiate- 
treated animals when compared to those of controls but 
this did not reach significance.
Males (see Table 3:10)
Hypothalamic DA levels were increased in the morphine-
treated males when compared to those of controls but this
did not reach significance. _
Homovanillic acid
Females (see Table 3:9)
No significant changes were recorded in HVA levels in
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opiate-treated females.
Males (see Table 3: 10)
Morphine treatment did not significantly alter 
hypothalamic HVA levels in male hamsters.
Serotonin
Females (see Table 3:9)
5HT levels were significantly elevated in the females 
treated postnatally with morphine.
Males (see Table 3:10)
5HT levels were significantly elevated in males treated 
postnatally with morphine.
5Hvdroxvindoleacetic acid
Females (see Table 3:9)
5HIAA levels were not altered in females treated 
postnatally with morphine.
Males (see Table 3:10)
5HIAA levels were significantly increased in males 
treated postnatally with morphine.
Discussion
Because of the great variation in the hypothalamic 
amine levels between the different treatment groups, it is 
difficult to correlate the changes recorded here in pups 
culled at day 12 with the alterations in behaviour
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reported in Chapter 2. In particular, from the present 
investigation, it would appear that amine levels in 
females are more susceptible to change than those in 
males. Significant changes were noted in some groups of 
females in each of the amines measured, while only 5HT and 
DA levels were significantly altered in the males.
Within each sex, treatments had opposite effects when 
given over different periods. In females, morphine alone 
had no effect on DA orits metabolite HVA yet testosterone 
given concurrently with morphine pre + postnatally 
increased DA levels, and when given postnatally decreased 
these. The two treatments had similar effects in males. 
It would appear therefore, that long-term exposure to both 
morphine and androgen has enhanced the development of the 
dopaminergic neuronal systems or increased the 
hypothalamic dopaminergic content, while short-term 
postnatal exposure has had an inhibitory effect on these. 
Why there should be such a difference in results is 
unclear, particularly since the former treatment overlaps 
with the latter. Further investigations into the effects 
of androgens alone over the same periods would perhaps 
help to clarify these data. The concentrations of the DA 
metabolite HVA differed little between the treatments, 
suggesting that the reduction in DA levels after morphine 
+ testosterone treatment is due to synthesis inhibition 
rather than to increased turnover.
In contrast to DA, 5HT seems much more sensitive to 
perinatal manipulation in both sexes, although again there
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is considerable variation between the treatment groups. 
Prenatal morphine administration significantly reduced 
hypothalamic 5HT and 5HIAA levels in females at postnatal 
day 12, while concurrent administration of androgen 
reversed this effect. On the other hand, neither of the 
other morphine-only treatments significantly affected 5HT 
levels,although testosterone treatment in conjunction with 
morphine postnatally significantly lowered 5HT but not 
5HIAA. Postnatal androgen administration has been shown 
to lower day 12 hypothalamic 5HT levels in the rat 
(Ladosky & Gaziri, 1972; Giulian et al. 1973) or have no
effect (Siddiqui et al. 1989)
Day 12 5HIAA levels were significantly decreased by 
postnatal naltrexone administration in females while 5HT 
remained unaltered, suggesting an increased clearance of 
the metabolite from the system, or perhaps a reduction in 
5HT synthesis.
5HT levels were increased in 12 day old males as 
a result of prenatal morphine + testosterone treatment, 
without a concurrent rise being seen in the hypothalamic 
5HIAA content. This treatment resulted in increased 
feminine sexual behaviour in males, as also did pre and 
postnatal morphine administration, (see Chapter 2 Expt 2) 
which also significantly increased 5HT levels at 12 days 
postnatally. The increase in 5HT caused by morphine 
treatment pre + postnatally was reversed by concurrent 
testosterone administration which caused a corresponding 
change in sexual behaviour.
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These changes in 5HT levels in males, coupled to the 
alterations previously reported in behaviour, suggest a 
role for the serotonergic system in the defeminization 
process. Control levels of 5HT are higher in the female 
rat and hamster hypothalamus at day 12 than in the male 
(Ladosky & Gaziri,1972; Giulian et al. 1973, Siddiqui et
al, 1989; Johnston et al. 1990). Manipulation of these 
levels results in alterations to adult sexual behaviour 
(Wilson et al.1986; Johnston et al. 1990). This suggests
therefore, that some of the behavioural changes reported 
in the present investigation may have been mediated via 
alterations to the hypothalamic serotonergic system at a 
time when neurotransmitter concentrations are sexually 
dimorphic.
Investigations into the ontogeny of the serotonergic 
system in the rodent reveal that 5HT neurones are 
detectable as early as Ell in the medial raphe of the rat 
(Lauder et al. 1982). 5HT occurs in high concentrations
prior to assuming its role as a neurotransmitter and is 
thought to act as a developmental signal prior to acting 
as a neurotransmitter. Inhibition of 5HT synthesis in 
vivo results in retardation of cell differentiation 
in those areas innervated by 5HT neurones or in the 
regions where 5HT is found in high concentrations (Lauder 
& Krebs, 1978). pCPA administration from day E12 to birth 
increases 5HT receptor numbers, while 5HT antagonist 
administration down-regulates receptor numbers in the
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newborn rat pup (Whitaker-Azmitia et al. 1987). Although
this change in receptor numbers is temporary (they match 
control levels by postnatal day 15) , they are reduced 
during a period of rapid neuronal change in the young 
rodent when neuronal maturation, growth and synaptogenesis 
are occuring and when adult patterns of sexual behaviour 
are being established. Thus, treatments which alter 5HT 
concentrations [and possibly receptor numbers] during this 
period may also cause changes in adult sexual behaviour 
patterns as a result.
In the second experiment, pups were culled at day 4 
postnatally within 3-4 hours of morphine administration 
and the hypothalamic amine levels were measured. The 
results from this experiment indicate that, in the short­
term, 5HT levels are significantly increased by opiate 
treatment. Similar findings were recorded in the adult 
female rat after morphine administration (Gopalan et al. 
1989). Whether these effects could be reversed by 
antagonists or steroid administration is not known. 
Further studies utilising both NTX and testosterone would 
be required to establish this.
From these two sets of experiments it has been shown 
that transient changes in hypothalamic monoamine levels 
occur as a result of perinatal administration of opiates. 
Some of the effects are longer-lasting than others and the 
administration of androgen along with the opiate appears, 
in some cases, to prolong the effect. While the 
variability in results makes their interpretation
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difficult, it is possible that the short-term changes in 
5HT levels in males may be correlated to the alterations 
recorded in adult sexual behaviour.
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H y p o t h a l a m i c  a m i n e  leve ls  in 4 -d a v  old h a m s t e r s
t r e a te d  p e r in a ta l lv  with m o r
F e m a l e s
T r e a tm e n t n DA HVA 5HT 5HIAA
co n t ro l 5 71 + 23 130 + 61 159 + 74 334 + 105
morphine 6 129 + 30 127 + 21 438 + 66** 393 + 45
t values 1.76 n.s. 0.05 n.s. 3.30 p<0.01 0.62n.s.
Table 3:9 Hypothalamic amine levels in 4 day female hamsters.
Group means + SEM
** differs from controls p<0.01
Males
T r e a tm e n t n DA HVA 5HT 5HIAA
c o n t ro l 5 53 + 17 76 + 22 112 + 14 216 + 35
m orphine 6 150 ±  56 120 + 22 373 + 48** 369 + 26**
t values 1.88 n.s. 1.63 n.s. 5.88 p<0.01 4.15 p<0.01
Table 3:10 Hypothalamic amine levels in 4-day male hamsters.
Group means + SEM
** differs from controls p<0.01
Chapter 4 
The effect of opiate exposure on two separate sexually 
dimorphic areas of the CNS
1) The Spinal Nucleus of Bulbocavernosus
The spinal nucleus of bulbocavernosus (SNB) is located 
in the dorsomedial aspect of the ventral horn of the spinal 
cord between segments L5 and SI; its motor neurones 
innervate the perineal muscles bulbocavernosus (BC) and 
levator ani (LA). These muscles are involved in copulatory 
reflexes in the male (Breedlove & Arnold, 1980; Sachs, 
1982; Hart & Melese d'Hospital, 1983). At birth, the 
muscles and their motor neurones are present in both sexes, 
but in the absence of androgens in females during the early- 
postnatal period the muscles atrophy, and the neurone 
numbers fall from around 300 to less than 50 (Cihak, 1970; 
Breedlove & Arnold, 1980). There is also a slight decrease 
in neurone numbers in the male, from 3 00 to approximately 
250 (Breedlove & Arnold, 1980).
The survival of this nucleus and its target muscles is 
dependent on androgens around the time of birth. This is 
indicated by the regression of both in neonatally castrated 
males, but their retention in females treated with 
testosterone on day two postnatally (Breedlove & Arnold, 
1983) . Interestingly, in Sprague-Dawley rats testosterone 
aromatization is not required for the retention of this 
nucleus and its muscles. Testosterone and DHT have both
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been found to be equally effective in preventing the 
degeneration of the SNB nucleus and its muscles, but they 
do not survive after oestrogen administration (Breedlove 
et al. 1982). However in the Albino-Swiss rat ( the strain 
used in this experiment), oestradiol benzoate administered 
postnatally reduced cell death in females, but did not 
maintain the muscles (Currie et al. 1990).
Since opiates are known to have an adverse affect on 
the survival and growth of neurones in culture (Davila- 
Garcia & Azmitia, 1989), it seems possible that exposure 
to morphine in the early postnatal period at the time when
cell numbers are very labile, could be detrimental.
Furthermore, in vivo, opiates suppress LH release which 
is needed to stimulate androgen production. This effect is 
a second and much more specific reason why morphine might 
act on the SNB. Thus rat pups were used to study the
effects opiates might have at this time.
Materials and methods
Albino-Swiss male rat pups were given one of the
following three morphine treatments at birth:
1) Duromorph 5mg/kg s.c. twice daily from day of birth 
for 4 days n = 10 males
2) Duromorph lOmg/kg s.c. twice daily from day of birth 
for 4 days n = 6 males
3) Duromorph 15mg/kg s.c. twice daily from day of birth 
for 4 days n = 6 males
Controls were given saline n = 7 males, 6 females
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Pups were weaned at 21 days and housed with litter 
mates, 3-4 per cage, with water and rat pellets available 
ad libitum. At three months of age the animals were culled 
by anaesthetic overdose and the tissues fixed by cardiac 
perfusion. 100 ml of Mammalian Ringer solution containing 
lignocaine was first infused and this was followed by 500ml 
of Millonigs buffer (pH 7.4) containing 10% formalin. 
Carcases were pinned out onto cork boards and the testes, 
epididymides, seminal vesicles, penis and its musculature 
dissected out and weighed. The spinal cord was then removed 
and stored in buffered formalin until sectioned.
Pieces of cord were cut such that levels L5 to SI (the 
area where the SNB neurones are located) were in the centre 
of the tissue to be sectioned. The pieces of cord were 
embedded in 7% agar and sectioned at 100/xm on a Vibratome. 
Sections were stained with 0.033% thionine in 70% alcohol. 
Thionine stains the cell bodies of neurones dark blue, but 
the nuclei remain pale with dense blue-black nucleoli. The 
motor neurones are very large and can easily be identified 
by their size (see figures 4:l-4:6). The individual cells 
can be readily counted using a light microscope. Only 
those cells were counted in which the nucleolus could be 
seen and no correction was made for cell size.
99
Fig.4:1
■
' ■
. ■ <*. ' ,3 •r
:
Photomicrograph of a section of spinal cord 
from an intact male Albino Swiss rat at level L45. 
Stained with Thionine. (x58)
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Fig.4:2 Photomicrograph of a section of spinal cord from an 
intact male Albino Swiss rat at level L5.
Stained with Thionine. (x58)
Fig.4:3 Photomicrograph of a section of spinal cord from an 
intact male Abino Swiss rat at level L6.
Stained with Thionine. (x58)
Fig.4:4 Photomicrograph of a section of spinal cord from a 
male Albino Swiss rat at level S1.
Stained with Thionine. (x58)
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Photomicrograph of a section of spinal cord from an 
intact male Albino Swiss rat at level L5.
Stained with Thionine. (x58)
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Photomicrograph of a section of spinal cord from an 
intact female Albino Swiss rat at level L5.
Note: no obvious SNB nuclei are present.
Stained with Thionine. (x58)
Fig.4:5
Fig.4:6
Photomicrograph of a section of spinal cord from an 
intact male Albino Swiss rat at level L5.
Stained with Thionine. (x58)
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Photomicrograph of a section of spinal cord from an 
intact female Albino Swiss rat at level L5.
Note: no obvious SNB nuclei are present.
Stained with Thionine. (x58)
Results
Control males had 212 ± 8  SNB motor neurones while 
those in the control females averaged 4 0 ± 2. Those males 
in Group 1 averaged 222 ± 7; those in Group 2 2 01 ± 4 and
those in Group 3 averaged 2 08 ± 6 motor neurones. None of 
these values differed significantly from those in the 
controls demonstrating that postnatal opiate exposure did 
not alter motor neurone numbers. Furthermore there were no 
significant differences between the weights of the genital 
organs in any of the treatment groups when compared with 
those in the controls. (See Table 4:1).
Discussion
This experiment indicates that motor neurone numbers in 
the SNB are unaffected by postnatal exposure to morphine. 
In adulthood, morphine suppresses LH output and 
consequently lowers serum testosterone concentrations 
(Cicero et al, 1976) . If this also occurs in neonates,
then it might have been expected that some loss of motor 
neurones would result from the reduced testosterone 
concentrations. Although no changes in neurone numbers 
were found it is possible that, a reduction in testosterone 
did occur, but was insufficient to reduce the survival of 
these neurones.
A second consideration that must be taken into account, 
is the timing of the injections. Treatment did not begin 
until all pups in a litter were born, and some litters were
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born during the night prior to treatment and were therefore 
not treated until several hours after birth. Analysis of 
testoterone levels on the day of birth in the rat, mouse 
and hamster pups by Pang et al. 1979; and by Slob et al.
1980) indicate that testosterone levels rise from the time 
of birth and reach a peak at around 6 hours post-partum. 
In experiments on adult rats, testosterone levels begin to 
fall approximately 1 hour after opiate administration. 
When these two factors are taken into consideration it may 
well be the case that in this experiment the morphine was 
given too late to have any appreciable effect on the 
androgen levels and consequently on SNB motor neurone 
numbers. However, castration on the day of birth does 
result in a decrease in numbers of motor neurones. 
Therefore, since castration results in a rapid and almost 
complete loss of androgens, while opiate administration 
produces a reduction in androgen levels, it would appear 
from these results, that either levels have not decreased 
enough to have an effect, or that normal, albeit low levels 
in the days after treatment are sufficient to prevent cell 
loss.
In vitro experiments on neurone culture have indicated 
that opiates have an inhibitory action on neurite growth 
(Davila-Garcia & Azmitia, 1989) . However, by the time of 
birth in the rat, neurogenesis of the SNB motor neurones is 
complete (Breedlove, Jordan & Arnold, 1983) and androgens 
are only required to prevent their regression due to
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controlled cell death (Breedlove & Arnold, 1983) . It is 
thus not surprising, that morphine when administered 
postnatally has no direct affect on the neurone numbers. 
It might be of interest in future studies to investigate 
the effects of prenatally - administered morphine on SNB 
motor neurone numbers, particularly by giving the drug 
from the early stages of neurogenesis. If such treatments 
did affect the numbers of SNB cells, one would need to 
determine by which means did it do so;
a) Did it inhibit neurogenesis? or
b) Did it reduce androgens such that greater then normal 
cell death occured in males. Using females as controls may 
help to distinguish between the two effects, since the SNB 
motor neurones develop similarly in both sexes, and only at 
the late stages of development does sexual differentiation 
occur, in that there is greater cell death in females due 
to the absence of androgens. If the treatment affects 
neurogenesis then, by culling the animals at the stage 
prior to differentiation, one should see a reduction in SNB 
neurone numbers at this stage in both sexes. 
One unexpected finding in this experiment was that the BC 
muscle weights in the 5mg/kg morphine-treated males were 
significantly higher than those in the other experimental 
groups when analysed using Least Significant Differences 
tests in analysis of variance. This observation suggests 
that at this dosage opiates have enhanced the development 
of the muscle or had the least detrimental effect. The 
group treated with 5mg/kg of morphine also had the highest
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number of SNB motorneurons although they did not differ 
significantly from other groups. The BC is the target 
muscle for the SNB thus it may be as a result of the 
increased muscle mass that there is a concurrent rise in 
SNB motoneurone numbers.
In conclusion, postnatal administration of morphine at 
a dose similar to and higher than one which has 
significantly altered adult sexual behaviour in another 
rodent species (see Chapter 2) had no effect on the number 
of motor neurones of the SNB in the Albino-Swiss rat.
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C om par ison  of M o to r  n e u ro n e  n u m b e r s  in Spinal nucleus of 
h u lhocavernosus ,  muscle  and  organ  weights  in female, male 
and neon a ta l ly  m o r p h in e - t r e a t e d  males .
Rats
t r ea tm e n t n tes tes  
weight (g)
BC weight
( g )
LA weight
( g )
IC weight
( g )
no. of SNB
motor
neurones
control
females
6 40+2 **
control
males
7 2.5±0.04 0 . 7 0  + 0 . 0 0 . 3 4  + 0 . 0 2 0 . 2  5 ± 0 . 0 1 212+7
5 m g /k g
Durom
1 0 2.6±0.04 0 . 8  + 0 .0 1  
I _
0 . 3 5 + .0 . 0 1 0 . 2  3 ± 0 . 0 1 222+7
l O m g /k g
Durom
4 2.5±0.07 0 . 6 ± 0 . 0 2 0 . 3  3 ± 0 . 0 0 0 . 2 3 ± 0 . 0 1 201+4
15 m g / k g  
Durom
3 2.5+0.03 0 . 6  + 0 . 0 7 0 . 3  2 ± 0 . 0 2 0 . 2 0 ± 0 . 0 2 208+6
F value 0.51 n.s. 12.9
p< 0.01
1.11 n.s. 1.44 n.s. 141.8
p<0.01
Table 4:1 Testes and muscle weights of adult rats treated postnatally 
with morphine.
Group means + SEM.
** differs from all other groups p<0.01 
§ differs from lOmg/kg and 15mg/kg-treated groups p<0.05
2) The sexually Dimorphic Nucleus of the Preoptic Area.
In 1978 Gorski and colleagues described a region of 
the rat preoptic area so strikingly different in size 
between the sexes, that when the brain is sectioned the 
difference is visible with the naked eye. This region, 
termed the sexually dimorphic nucleus of the preoptic area 
(SDN-POA), is many times larger in males than in females 
(see figs 4: & 4: ) and has also been identified in the
guinea-pig, mouse and hamster, (Byne & Bleier,1987; Byne et 
al, 1987) Bleier et al, 1982), the ferret, (Tobet et al.
1986) and in man (Swaab & Hofman, 1988) . Its size is 
determined by the hormone mileu during the perinatal 
period. Gorski et al (1978) reported that male castration 
on the day of birth reduced the volume of the adult male 
SDN-POA by approximately half, while a single injection of 
(TP) to female pups during the early postnatal period 
doubled its size; neither treatment wholly sex-reversed 
the volume of the nucleus. Jacobson et al (1981) produced 
further evidence that the SDN-POA volume is androgen- 
dependent by showing that TP given to male rat pups on day 
2 after birth reversed the effects of castration on day 1. 
Dohler et al (1982) reported that TP administered 
throughout the last trimester of gestation and up to day 10 
postnatally completely sex-reversed the SDN-POA volume in 
females. The same authors stated that
1) both TP and diethylstilboestrol (DES) were equally 
effective in sex-reversing the size of the SDN (Dohler
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et al.1984a) and
2) that a potent oestrogen antagonist (Tamoxifen) given 
postnatally, significantly reduced the volume of the SDN- 
POA in both sexes (Dohler et al. 1984a) . This indicates
that oestrogen plays an active role in both the 
mascul inization of the SDN-POA in males and in the 
development of this nucleus in females.
In the rat, the SDN-POA consists of 3 major 
subdivisions. The cell dense central (MPNc) and medial 
(MPNm) subdivisions are larger in the male, while the 
lateral subdivision (MPN1) , with few cells, is the major 
division of the female nucleus. Neurones containing a 
variety of neurotransmitters have fibres passing through 
the nucleus or have their cell bodies located within it. 
These neurotransmitters are not homogeneously distributed 
within the nucleus (Simerly et al, 1986) and include
serotonin (5HT) oxytocin (OXY) and leucine-enkephalin (L- 
ENK) . Simerly et al (1984) investigated the 5HT input to 
the SDN-POA and reported a sexual dimorphism in serotonin 
distribution within the nucleus, there being significantly 
more 5HT fibres per unit area in females than in males. 
Hypothalamic 5HT levels are reported to be sexually 
dimorphic on day 12 postnatally in the rat (Ladosky & 
Gaziri, 1970), and in the hamster (Johnston et al, 1990).
Experimental reductions in 5HT levels during the perinatal 
period sex reversed the volume of the SDN-POA in female rat 
pups (Handa et al, 1986) , but it is not clear if the
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effects are lasting (Hines & Gorski, 1986) . Postnatal 
reduction of 5HT in hamsters increases the amount of 
feminine sexual behaviour displayed in adulthood by males 
while reducing it in females (Johnston et al. 1990). It
has been shown that 5HT may be involved in directing the 
genesis and/or migration of neurones which receive a 5HT 
innervation in adulthood. (Lauder & Krebs, 197 6; Lauder & 
Krebs, 1978; Lauder et al. 1982).
Hammer (198 4) reported that the SDN-POA in the rat 
contains denser opiate binding sites in females than in 
males. Since opiates are known to inhibit neural
outgrowth in vitro (Davila-Garcia & Azmitia, 1989) and in 
vivo (Hammer et al, 1989) this difference in receptor
density may be involved during the perinatal period in the 
control of development. Furthermore as opiates have also 
been reported to alter levels of 5HT in adulthood (Gopalan 
et al, 1989) , it is therefore possible that exposure to
exogenous opiates during the period of sexual 
differentiation may be detrimental to SDN-POA 
masculinization. To investigate this possibility rat pups 
were treated postnatally with morphine and their brains 
examined for morphological changes in adulthood.
Materials and Methods.
Male rat pups were treated postnatally from the day of 
birth as follows:
1) Saline-treated controls (n=3)
2) lOmg/kg Duromorph subcutaneously twice daily from day
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of birth for 4 days (n=5)
3) 15mg/kg Duromorph s.c. twice daily from day of birth
for 4 days (n=5).
At 21 days animals were weaned and housed in groups of 
2-3 littermates of the same sex which had received the same 
treatment.
At 3 months of age each animal was culled by a lethal 
dose of sodium pentobarbitone (Sagatal) and perfused 
intracardially with mammalian Ringer solution with added 
Lignocaine, followed by 10% buffered formalin. The brain 
was rapidly removed and fixed for a minimum of 2 weeks in 
10% formalin before being processed. Following fixation 
brains were embedded in agar and sectioned in the DeGroot 
(1959) plane on a Vibratome. Sections were 100/xm thick and 
were stained with thionine (0.2% in 70% alcohol pH 4.5), 
dehydrated through an alcohol series and mounted on glass 
slides. Each section in which the SDN-POA was identified, 
was photographed using an Ultraphot microscope and camera, 
at a magnification of x 32. The area of the SDN-POA was 
outlined on the photograph and measured using a MOP AM02 
planimeter.
The volume was calculated as follows:
Area of nucleus X thickness of section 
Magnification2
In the first and last section in each group, the SDN- 
POA was assumed to occupy only half the thickness of the 
sections.
The volumes of the SDN-POA in each group were analysed
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statistically using one-way analysis of variance, followed 
by intergroup comparisons based on Confidence Intervals; a 
difference of p<0.05 was taken as significant.
Results
Control males had an average SDN-POA volume of 0.0339 ± 
0.003mm3 while males treated with lOmg/kg morphine had a 
SDN-POA volume which averaged 0.0525 ± 0.004mm3 and those 
treated with 15mg/kg had a SDN-POA volume that averaged 
0.0442 ±0.007mm3.
One way ANOVA gave an F value of 1.08 (not significant).
Discussion
The results obtained indicate that postnatal exposure to 
exogenous opiates had no significant effect on the size of 
the SDN-POA. This is interesting since there are two 
reasons why one might expect an effect to occur.
1) Since opiates are known to lower the levels of 
testicular androgens by suppressing LH secretion (Singh et 
al, 1980; Genazzi & Petraglia, 1989), and castration on day 
of birth reduces the volume of the SDN-POA, it might have 
been expected that opiate exposure during this period would 
reduce the volume of the SDN-POA.
In male rats a surge of testosterone, reaching a peak 
approximately 6 hours postnatally and falling again to 
basal levels within 24hrs of birth, is believed to 
contribute to the masculinization of the SDN-POA. However,
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Handa et al, (1985) reported that there was no difference
in volume of the SDN between pups castrated at 0, 6 or 24
hrs postnatally. All three groups showed a similar 
reduction in volume, indicating that the postnatal surge of 
testosterone is not critical to the differentiation of this 
nucleus. Therefore, if we assume that the treatment regime 
described in this experiment does reduce or delay this 
testosterone surge, it might still not affect the SDN-POA 
volume.
2) Conversely, if opiates inhibit growth and 
synaptogenesis, then again we might expect to see an effect 
on SDN-POA volume. However, neither dose used here 
appears to have any influence on the SDN-POA, although it 
is possible that the timing of treatment was later than 
that around when the drug would have any effect i.e. the 
drug may have been given after the postnatal surge of 
androgen had been produced. Investigations into the
effect of prenatal stress on sexual differentiation of the 
rodent CNS, have indicated that stress induces a variety of 
changes in the animals1 behaviour in adulthood (Ward, 1983; 
Herrenkohl, 1983). In general the changes reflect 
feminization of behaviour. The preoptic area is known to be 
involved in the control of sexual behaviour and lesions to 
this area increase the amount of lordosis displayed by 
males (Hennessey et al. 1986). This has led to the
proposal that the additional volume in males may be 
inhibiting feminine behaviour, since when the SDN-POA is
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ablated this inhibition is removed. Prenatal stress also 
results in:-
1) a reduction in mounting and an increase in feminine
sexual behaviour in male rats ( Ward, 1983), and
2) a reduction in the volume of the SDN-POA (Anderson et 
al,; Anderson et al. 1986).
The latter authors were also able to demonstrate a
positive correlation between the volume of the SDN and the 
amount of mounting displayed by male rats.
Prenatal stress upsets the timing of a particular
androgen surge in male rat fetuses. There is a dramatic 
rise in testosterone on day 18 which begins to fall on day 
19 and has reached basal levels by day 2 0 (Weisz & Ward, 
1980). Prenatal stress advances the timing of this rise to 
day 16, and by embryonic day 18 levels are significantly 
lower than in control fetuses (Ward & Weisz, 1980). A 
similar pattern occurs in response to prenatal exposure to 
morphine (Ward, Orth & Weisz, 1983). The effects of both 
stress and morphine exposure on testosterone levels during 
the fetal period can be prevented by prior administration 
of NTX (Ward, Orth & Weisz, 1983). The above mentioned
investigations have shown that
1) prenatal exposure to morphine mimics the effects of 
prenatal stress on adult sexual behaviour. The 
effects of both can be prevented by NTX treatment.
2) prenatal stress reduces the volume of the SDN-POA. 
It would therefore be interesting to look at the
effects of prenatal (rather than postnatal as in this
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experiment) morphine on the volume of the SDN-POA. It 
seems quite feasible that opiate exposure during the last 
trimester of pregnancy might well reduce the SDN-POA 
volume.
Ill
Fig. 4: Serial photomicrographs through the medial
Preoptic area of a normal male Albino Swiss rat. The 
sections run in rostral-caudal sequence from top to bottom. 
This shows the extent of the male SDN-POA (red asterisk). 
Various other structures labelled serve as topographical 
markers and have been indicated as they emerge.
This represents an example of the photomicrograph series 
of serial sections from which the volume of the SDN-POA was 
calculated.
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SO - Supraoptic nucleus
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Fig. 4:8 Serial photomicrographs through the MPOA of a 
normal female Albino Swiss rat. The sections run in 
rostral-caudal sequence from top to bottom. This shows the 
limited extent of the female SDN-POA (red asterisk). 
Various other structures labelled serve as topographical 
markers and have been indicated as they emerge.
This should be directly compared with Fig. 4:6.
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Chapter 5 
General Discussion 
Perinatal exposure to opiates affects different aspects of
behaviour.
Opiate administration during the perinatal period has 
been been reported to affect behaviour in different ways 
and in varying degrees. Grove et al (1979) found that 
exposure to methadone prenatally, postnatally or both 
resulted in pups which were hypoactive in open field tests 
at postnatal day 28, but were hyperactive and less 
emotional in the same test as adults. Zagon et al (1979) 
reported similar findings in rats treated prenatally with 
methadone. In contrast, Davis & Lin (1972) noted that rats 
were hyperactive as pups and as adults in open-field tests 
after prenatal exposure to morphine.
In competition with controls for access to drinking 
water, rats exposed to methadone pre- and postnatally spent 
less time at the water-bottle; this was interpreted as 
reduced social dominance in these animals, (Thompson & 
Zagon, 1983).
Rats exposed prenatally to methadone were 
hypersensitive to aversive stimuli and acquired avoidance 
and escape behaviours more rapidly than controls (Rech et 
al, 1980) . Conversely pre- and postnatal exposure to
morphine at several doses did not affect conditioned 
learning in rats when tested as adults (Banerjee, 197 5). 
Despite the apparent contradictions in results (which may
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be due to the type of drug, method of treatment and/or 
dosage), it seems likely that opiate exposure during the 
developmental period has adverse effects on the behaviour 
patterns of rodents later in life.
Perinatal opiates and adult sexual behaviour.
Adult sexual behaviour is also affected by opiate 
treatment perinatally. Meyerson (1982) treated male rats 
with the endogenous opioid /3-endorphin on days 1-5 
postnatally and noted a reduction in mounting behaviour as 
adults. Ward et al (1983) also found that prenatal 
morphine reduced masculine sexual behaviour in males rats 
and increased their ability to display lordosis. Vathy et 
al (1983) reported a partial inhibition of feminine sexual 
behaviour in female rats exposed prenatally to morphine.
Patterns of sexual behaviour are established during 
the perinatal period in rodents and are dependent on 
testicular androgens for masculinization and defeminization 
of behaviour in males. In the rat, the critical period for 
differentiation of sexual behaviour occupies the late 
prenatal and early postnatal period whereas, in the 
hamster, the critical period was initially believed to be 
wholly postnatal (Nucci & Beach,1971). However, treatment 
with antiandrogens during gestation reduces the males 
ability to display masculine sexual behaviour as adults 
(Swanson, 1971). Studies on androgen levels in the fetal 
rat have shown that the elimination of a prenatal surge of 
testosterone on days E18.5-19.5 results in males which show
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increased feminine patterns of behaviour and decreased 
mounting (Ward & Weisz, 1980). A more recent investigation 
of plasma androgen levels in the fetal hamster at E14 & E15 
(gestation period 16 days) revealed a significantly higher 
level of testosterone in the plasma of males compared with 
females (Vomachka & Lisk, 1986). Fetal androgen levels in 
the male hamster were found to be 10-fold lower than in the 
fetal male rat at an equivalent stage, and the authors have 
suggested that sexual behavioural differences between these 
two species as adults may be related to this. Thus, male 
rats, which are exposed to relatively high levels of 
androgens prenatally, show masculine sexual behaviour as 
adults but do not display lordosis. Female rats and male 
hamsters can show either lordosis or mounting depending on 
the hormone priming given to them in adulthood; these 
animals are exposed to intermediate levels of androgens 
prenatally. Female hamsters, which seldom display 
masculine behaviour even after priming, have very low 
perinatal plasma androgen levels. If this is so, then 
reduction of androgen levels during the perinatal period, 
or a change in the ability of the CNS to respond to them, 
might result in a shift of adult sexual behaviour 
capacities to that of the opposite sex. In the present 
investigation, just such a shift occured in male hamsters 
exposed both before and after birth to morphine. This 
might not be considered surprising given that opiates 
suppress LH and, therefore, androgens (Cicero, 1980) .
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However, although the amount of feminine sexual behaviour 
was significantly increased, masculine sexual behaviour was 
unaffected by opiate treatment although as expected the 
changes could be reversed by androgens and naltrexone. 
A second paradox is that, in male hamsters chronically 
exposed to morphine, both feminine and masculine sexual 
behaviour were significantly enhanced. If the opiate 
action were mediated via androgen reduction, one would have 
expected this group to show more feminine and less 
masculine behaviour. However it is possible that long-term 
exposure to opiates produces less effect than short-term 
exposure or that treated males are more sensitive to 
androgens during the critical period.
How then do opiates mediate this reported change in 
behaviour?
Having shown that morphine does alter sexual 
behaviour, attempts were made to elucidate whether the drug 
mediated the changes through reduced androgen levels or by 
some other mechanism. Reports on plasma androgen levels in 
the golden hamster indicate that levels in male pups are 
significantly higher than in females on the day of birth 
and for up 5 days postnatally (Pang & Tang, 1984; Vomachka 
& Greenwald, 1979). Therefore androgen levels in male pups 
treated postnatally with morphine were compared to those of 
untreated 2 day-old males. No significant difference in 
testosterone levels was noted. This suggests that the 
alterations in sexual behaviour in the males were unlikely
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to have been caused by postnatal androgen reduction. 
However, since behavioural changes were more marked in 
males to which opiate exposure had been extended into the 
prenatal period, the possibility that androgen levels may 
have been reduced during this prolonged exposure cannot be 
fully excluded. Further work is required to determine if 
this is so. In addition, since perinatal levels of 
androgens in the golden hamster are much lower than in the 
rat (Vomachka & List, 198 6) it may be that subtle changes 
in concentrations go undetected in this species, whereas 
relatively small changes in rat testosterone levels would 
be quite obvious. In a further attempt to determine
whether the opiate-induced changes in behaviour were 
mediated via reductions in androgens, it was decided to 
look at two different androgen-dependent structural 
dimorphisms in the CNS. In this study a different species 
was employed, the Albino-Swiss rat, since in this species 
the structures in question, the SDN-POA and the SNB, have 
received considerable attention and require perinatal 
exposure to testosterone to be masculinized. The SDN-POA 
is many times greater in volume in the male than in the 
female (Gorski et al, 1978). Postnatal castration reduces 
the volume and androgenisation of females on day 1 
postnatally increases it, but neither treatment wholly sex- 
reverses it. Oestrogen is equally effective in increasing 
the size of the SDN-POA in females. However extending the 
treatment time into the prenatal period does masculinize
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the female SDN-POA volume completely, while treatment with 
the antioestrogen tamoxifen will feminize the male SDN-POA 
(Dohler et al. 1983). If opiates reduce postnatal
androgens then one would expect to see a reduction in SDN- 
POA volume in opiate-treated males. In this investigation 
no reduction in volume was recorded. As with hamster pups 
(see above) a preliminary investigation into androgen 
levels in opiate-treated rats at 2 days postnatally did not 
show any difference between morphine-treated pups and 
controls.
The second morphological structure, the SNB is
dependent on postnatal androgens for neuronal survival. 
SNB motor neurone numbers in both males and females rats
are similar before birth. However, the presence of
testicular androgens in the postnatal male inhibits the
neuronal cell death which occurs in females, resulting in a 
nucleus with some 250 neurones in the male and 
approximately 40 of reduced size in the female (Breedlove & 
Arnold, 1981). Spinal cords from rats treated postnatally 
with different doses of morphine were sectioned, stained 
and the numbers of SNB motor neurones recorded. There was 
no significant difference in motor neurone numbers between 
the treatment groups and control males.
These two experiments give further evidence that the 
alterations in adult sexual behaviour reported in hamsters 
treated perinatally with opiates were unlikely to have been 
caused by a reduction in androgen levels during this period.
The monoamines arise very early on in development in
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the mammal (Coyle & Henry, 1973; Schlumpf et al. 1980;
Lauder et al, 1982) and at this stage are thought to be
involved in trophic events in development, possibly acting 
as a signal for differentiation and migration of neurones 
(see reviews Lanier et al. 1976; McMahon, 1974). In this
manner, they may play an active role in the establishment 
of behaviour patterns by regulating migration and 
synaptogenesis of neurones. However opiates have been 
shown to inhibit neuronal growth when administered 
prenatally, which could result in the differentiation 
signal occuring too late or in the wrong place. Therefore, 
the hypothalamic levels of neurotransmitters on day 4 and 
day 12 were measured. Unfortunately it was not possible to 
determine concentrations of NA levels in this study but DA, 
5HT and their metabolites HVA and 5HIAA respectively were 
analysed. Female hypothalamic DA and HVA levels were not 
altered by opiate treatment. Some changes were noted when 
testosterone or naltrexone was given with the opiate but it 
is difficult to relate these changes to alterations in 
behaviour since similar treatments over different time 
periods had opposite effects on transmitter concentrations. 
Similar results were recorded in the males.
Is 5HT the key?
On day 12 postnatally, the hypothalamic 
concentrations of 5HT are significantly higher in female 
rats (Ladosky & Gaziri, 1970; Siddiqui et al, 1989) and
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hamsters (Johnston et al. 1990) than in males.
Manipulations of 5HT levels during the neonatal period 
results in altered behavioural patterns in adulthood 
(Wilson et al. 1986; Johnston et al. 1990). Furthermore,
Lauder & Krebs (1978) have shown that changes in 5HT 
levels during development cause alterations in 5HT receptor 
numbers which, although transient, are sufficiently long 
lasting to encompass the critical period of sexual 
differentiation. Changes in 5HT concentrations can also be 
induced by perinatal androgen manipulation; castration on 
postnatal day 1 increases day 12 5HT levels to those of 
females, while androgenization of females postnatally 
lowers them (Ladosky & Gaziri, 1970).
The results from this study were very variable, but it 
was evident that 5HT was particularly susceptible to 
alteration over this period. The only morphine-treated 
group of females to show a reduction in feminine sexual 
behaviour were those treated prenatally with morphine; this 
group also showed a significant reduction in 5HT levels on 
day 12. Females treated postnatally with both morphine and 
testosterone also had a marked reduction in both feminine 
sexual behaviour and 5HT concentrations on day 12. 
Postnatal androgen treatment of female rat pups resulted in 
similar changes in amine levels (Giulian et al. 1973) and
behaviour (Whalen & Edwards, 1967).
Prenatal morphine + testosterone treatment had the 
most significant effect on sexual behaviour in males and 
this group also had significantly elevated levels of 5HT on
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day 12. Morphine treatment pre and postnatally raised 5HT 
levels and increased feminine sexual behaviour in males. 
Short-term effects of postnatal opiate exposure were most 
pronounced in that levels of 5HT were significantly 
increased in both sexes, although this appears to be 
transient since by day 12 these had returned to normal in 
many cases. However, these immediate alterations in 5HT 
concentrations may be sufficient at this time to interfere 
with the neural substrate which is involved in the 
defeminization process and could lead to males treated 
postnatally with morphine showing an increase in feminine 
sexual behaviour. It would appear therefore that 5HT is 
involved in the defeminization process in the golden 
hamster and that opiate administration mediates some of the 
altered sexual behaviour patterns reported in this study 
via changes in the serotonergic neural pathways. However, 
since not all of the changes in adult sexual behaviour were 
reflected in changes in monoamine levels on day 12 
postnatally, it cannot be assumed that these were all 
mediated via this system, nor indeed can it be assumed that 
those treatments which did alter both amines and behaviour 
were only mediated via this system. It is possible that 
the alterations in 5HT concentrations are merely 
consequential to actions occuring elsewhere as a result of 
opiate adminstration rather than being part of the process 
of change.
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In which other wavs could morphine have mediated the
changes reported here?
The endogenous opioid peptides and their receptors 
become apparent relatively early in the developing CNS, 
and have been detected in the fetal rat brain by days E12- 
E14 (Kent et al. 1982 ; Khachaturian et al. 1983). This
suggests that the endogenous opioids may play a regulatory 
function in neuronal development. The finding that chronic 
treatment with the opiate antagonist naltrexone results in 
neonatal rats which have larger brains than controls (Zagon 
& McLaughlin,1983) and increased dendritic arborization 
(Hauser et al. 1987) lends support to this hypothesis.
Investigations into the ontogeny of opiate receptor 
development have revealed regional and temporal development 
of the different receptor subtypes (Tavani et al. 1985;
Petrillo et al. 1987). Alterations to the distribution and 
timing of receptor differentiation may therefore result in 
changes in the neural substrates which they were destined 
to control. Opiate administration during the perinatal 
period has been shown to have many adverse effects on 
neuronal development, including inhibition of DNA 
synthesis, (Vertes et al, 1982 ; Kornblum et al , 1987)
reduced neuronal density and dendritic growth (Hammer et 
al, 1989) and defective synaptic development (Slotkin et 
al, 1979). Also of importance is the finding that
perinatal morphine administration down-regulates the number 
of ji receptors and pattern of met-enkephalin development 
(Tempel et al, 1988; Di Guilio et al, 1988). In this
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regard it is hardly surprising that patterns of sexual 
behaviour which are being laid down during this time were 
altered. However this does not tell us how the changes 
were made but merely suggests possible mechanisms of 
action. Of particular interest is the report by Slotkin et 
al (1979) that the development and synaptogenesis of 
monoaminergic systems were defective after perinatal 
methadone treatment; in the present investigation it was 
found that 5HT levels were altered by morphine in many 
cases.
In conclusion, opiate administration during the 
perinatal period markedly reduces defeminization in the 
male golden hamster. The changes recorded do not appear to 
be mediated via androgen reductions, but may be mediated 
via alterations to serotonergic neural pathways which have 
been shown to be involved in sexual differentiation of 
behaviour. However since the CNS is still undergoing 
considerable growth, maturation and synaptogenesis during 
this period, opiate-induced alterations to these processes 
cannot be ruled out.
What next?
During this investigation it was found that androgen 
administration with morphine prenatally resulted in males 
which showed significantly enhanced feminine and masculine 
sexual behaviour suggesting that defeminization may begin 
earlier than has been reported. Further studies giving
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androgens only may help to confirm this. In addition 
analysis of LH and androgen levels on the day of birth in 
males treated prenatally with opiates would be useful to 
determine whether these are suppressed by morphine in this 
species.
The possibility that prenatal opiates might alter the 
volume of the SDN-POA and motor neurone numbers in the SNB 
requires investigation. This should be coupled to androgen 
analysis to help to elucidate by which mechanism the 
changes, (if any) are mediated. This is particularly 
important since opiates have been shown to retard neuronal 
growth and may delay migration of the neurones into the two 
nuclei.
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Abstract
The primary purpose of this investigation was to study 
the effects that perinatal exposure to opiates might have 
on adult sexual behaviour in rodents (using the golden 
hamster as a model).
Subsequent aims were to elucidate the mechanisms by which 
such actions might occur. These included the effects of 
perinatal opiate exposure on
1) Hypothalamic biogenic amine levels during the perinatal
period.
2) Sexually dimorphic structures in the CNS of the
Albino-Swiss rat, especially
a) the spinal nucleus of bulbocavernosus
b) the sexually dimorphic nucleus of the preoptic area
3) Plasma testosterone levels during the neonatal period
in male hamster.
Opiate treatment had little effect on the females' 
ability to display sexual behaviour. By contrast, perinatal 
opiate administration resulted in alterations to the adult 
sexual behaviour of male golden hamsters. Masculine sexual 
behaviour was unaffected but the ability to display 
feminine sexual behaviour was markedly increased after pre 
+ postnatal or postnatal treatment with morphine. These 
changes in behaviour were reversed by both androgen and 
naltrexone treatment. However prenatal morphine and 
androgen administration markedly enhanced both feminine and 
masculine sexual behaviour in males, suggesting that the
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morphine-induced alterations to feminine behaviour may not 
have been mediated via an androgen-dependent mechanism. In 
addition, when the behaviour of males chronically exposed 
to morphine throughout gestation and during the early 
postnatal period was examined it was found that both 
masculine and feminine sexual behaviour was significantly 
enhanced. The following studies were undertaken with a view 
to determine how the opiate-induced alterations in 
behaviour were mediated.
1) Hypothalamic concentrations of DA, HVA, 5HT and 5HIAA 
were measured using an HPLC-ED system. Levels of 5HT in 
the rat and hamster are reported to show sex differences at 
this time (higher in females than in males) and 
manipulation of 5HT levels during the early postnatal 
period is known to interfere with sexual behaviour in 
adulthood. Prenatal administration of morphine
significantly reduced female levels of 5HT on day 12 
postnatally, this treatment also reduced feminine sexual 
behaviour. Postnatal morphine + testosterone reduced 
female 5HT levels and their lordosis behaviour. In 
contrast, levels of 5HT in males were increased by opiate 
treatments which also increased their ability to display 
lordosis. These results suggest that some of the changes 
reported in adult sexual behaviour may have been caused by 
alterations to the hypothalamic levels of 5HT in the golden 
hamster. When the levels of hypothalamic amines were 
measured in pups culled on the final day of morphine 
treatment, 5HT and 5HIAA concentrations were significantly
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increased in males and 5HT concentrations were raised in 
females.
2a) Rats treated with 5, 10 or 15mg/kg morphine for 4 days 
postnatally were culled as adults and the number of motor 
neurones in the spinal nucleus of bulbocavernosus counted. 
This nucleus is dependent upon postnatal testicular 
androgens to promote the survival of its neurones (around 
250 in males). The absence of androgens in females at this 
time results in the neurone numbers falling to around 40. 
None of the doses of morphine used had any significant 
effect upon motor neurone numbers in the male rats.
2b) The volume of the sexually dimorphic nucleus of the 
preoptic area (SDN-POA), which is significantly larger in 
the adult male than in the female rat, was measured in 
adult male rats treated postnatally with either 10 or 
15mg/kg morphine. No difference was noted in either group 
of males when compared to controls.
3) Testosterone levels in male hamster pups treated on 
days 1 and 2 with morphine and culled 2-3 hours after the 
final injection showed no significant change when compared 
to those of saline-treated males.
These studies have revealed that perinatal morphine 
administration alters the sexual differentiation of 
copulatory behaviour in the golden hamster. These 
alterations are apparently not mediated via a reduction in 
androgens. Neither androgen levels, as determined by
RIA, nor either of the androgen dependent structures in the
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CNS (SNB and SDN-POA) were altered by opiates.
It is possible that some of the alterations in sexual 
behaviour may have been mediated via alterations to 
hypothalamic levels of 5HT during postnatal development 
since some morphine treatments altered both these 
variables.
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